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Influenza 
Jack Edwards, '55 
INTRODUCTION 
The word "flu" today encompasses such a large variety of vague ailments 
and symptom-complexes that it would be impossible to discuss them aJI in this 
paper. Respiratory flu often refers to the common cold, and when a person says 
he has had stomach flu , it usually means he has spent a miserable night running 
to the toilet. In this paper, I shall attempt to describe influenza in its pure form. 
Before 1890, influenza was practicaJiy unknown, and except for a minor out-
break in 1855, was not a significant cause of death. In fact, it was becoming an 
almost extinct disease in Britain. .According to Burnet and Clark, influenza re-
mained endemic somewhere in Central .Asia until the spring of 1889, when its 
virulence became exalted in Bukhara. Other parts of Russia were affected in the 
fall , and by December the epidemic had spread to Western Europe. The 1889-90 
pandemic affected a large part of the world but was not associated with par-
ticularly high mortality for young adults. The first wave in January 1890 was 
succeeded by others in May 1891 and January 1892, causing progressively high 
mortality. Influenza has never since fallen to the pre 1889 low level and has 
become an important cause of mortality and morbidity in most temperate climates. 
In 1918-19, influenza accounted for the most lethal pandemic known in his-
tory. .According to Frost, there had been a steady increase in the mortality from 
influenza and pneumonia in New York betwee.n 1914 and 1918. It is questionable 
whether this progressive rise can be ascribed to the activity of influenza .A, or of 
any other single virus. In fact it is not known what led to the catastrophic events 
of 1918-19. In the early months of 1918 the influenza had no unusual properties, 
but in June in Britain, there was some indication that it was beginning to kill 
young adults . The really virulent form of the disease appeared at about the same 
time in the U.S.A. around Boston, and in Brest France - ports of embarkation 
and debarkation of .American troops corning to Europe. The rapid spread of the 
lethal kind of influenza all over the world is a familiar story. It is estimated 
that at least 15 million people died as a result. 
Mter the pandemic years, influenza gradually returned to its habits of killing 
the old and weak, rather than the young and vigorous. This reversion took at 
least three years in the U.S.A. and perhaps a decade in Britain. We may suppose 
that the 1918-19 influenza lacked some property enabling it to persist between 
epidemics, so that a less spectacular derivative gradually replaced it. 
Since the great pandemic the mortality from influe.nza has been falling and 
the peaks have been tending to be smaJier and more widely spaced. However, 
influenza is still an important cause of morbidity and lost working time as wit-
nessed in London this winter. 
DEFINITION AND ETIOLOGY 
Influenza is an acute, suddenly onset-
ting, infectious disease of viral etiology, 
usually occurring in epidemic form and 
characterized by general symptoms of 
fever, chills, headache, myalgia, and by 
mild upper respiratory symptoms. 
enza and bas since been proved to be only 
a common secondary invader of influenza. 
In 1892 Pfeiffer described a small gram 
negative bacillus, which grew with diffi-
culty upon blood media, as the causa-
tive agent of influenza. It is known as 
Pfeiffer's bacillus or Hemophilus influ-
In 1933 the true etiology was estab-
lished in England by Smith, Andrews, and 
Laidlaw, with the isolation of a vi rus from 
gargling of patients, during a typical 
epidemic of influenza. It was designated 
influenza A virus. 
In 1940 a second etiological type of the 
virus was isolated independently by Fran-
cis and Magill, known as influenza B 
VICUS. 
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A third type of virus, unrelated to 
either influenza virus A or B, was dis-
covered in 1947 by Taylor, and the name 
influenza virus C was proposed. 
In electron-micrographs of infected 
allantoic fluid, purified by centrifugation 
or by absorption on red-cell ghosts, the 
virus is seen as round or slightly ovoid 
particles measuring 80- 120 millicrons in 
diameter. The average size of influenza 
B virus is slightly larger than that of A. 
In addition, elongated forms have been 
observed, either as long filaments 1 mi-
cron or more in length or as shorter rods, 
and are thought to represent a laboratory 
form of influenza virus. Their exact re-
lationship to the spherical virus is still 
incompletely understood. 
The virus is readily destroyed by heat-
ing, and by treating with disinfectants. 
It can be preserved at very low tempera-
tures. The virus can be recovered from 
throat washings early in the illness but 
has never been found in the blood stream. 
Influenza virus consists of at least two 
distinct components, the elementary body 
and the soluble substance. The properties 
of the two differ considerably. 
The soluble substance is made up of 
small particles with an average diameter 
of about 10 millimicrons. Soluble sub-
stance can be demonstrated only by com-
plement-fixation tests, in which it acts as 
a powerful antigen. Antibodies against 
soluble substance develop only after in-
fection, not after vaccination. The par-
ticles are not infective, are not absorbed 
on red blood cells, and do not cause 
hemagglutination. 
The elementary bodies are considerably 
larger, their diameter being 8- 120 milli-
microns. Studies have shown that virus 
infectivity is intimately associated with 
these bodies. Furthermore, the element· 
ary bodies react with red cells and cause 
hemagglutination. Animals immunized 
with this component develop virus-neu-
tralizing and other antibodies, and be-
come resistant to influenza infection. The 
elementary bodies also fix complement in 
the presence of immune serum, but the 
antigen is different from that of the 
soluble substance. 
The strains of human influenza virus 
known at the present time can be divided 
into three distinct and immunologically 
unrelated types which are referred to as 
influenza A, B and C. In addition there 
are the swine influenza viruses which are 
serologically related to influenza A virus. 
While A and B viruses have been widely 
investigated, not much is known about 
the antigenic structure of influenza C 
virus. 
The soluble substance contains only a 
single antigen which is type-specific, that 
is, all strains of influenza. A virus con-
tain the same soluble antigen, which is 
quite distinct from that present m m-
fluenza B virus strains. 
The elementary bodies contain several 
distinct antigenic components, and in-
dividual strains belonging to the serologi-
cal type virus may differ considerably 
from one another as regards antigenic 
constitution. Thus, although all influ-
enza A strains are immunologically re-
lated, marked differences in the antigenic 
pattern of individual strains can be easily 
differentiated in cross-tests with different 
virus strains and their antisera. Similar 
variations have been recognized also 
among individual strains of influenza B 
virus, whereas only one serological type 
of influenza C is known. 
Comparisons of antigenic pattern of in-
fluenza virus strains can be carried out 
by a number of methods, such as cross-
neutralization tests in mice, and hemag-
glutination-inhibition and complement-
fixation tests using elementary-body sus-
pensions as antigen. In recent years, the 
hemagglutination-inhibition test has been 
preferred by most workers because it is 
technically the simplest and is the least 
expensive me~hod. 
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Attempts have been made to segregate 
the virus strains of each serological type 
(A, B and C) into subtypes. All strains 
of influenza A virus so far examined can 
thus be divided into three main groups 
according to their relationship to the 
following three prototype viruses: WS 
(1933) , PR 8 (1934) and FM 1 (1947) . 
Similarly the B strains can be subdivided 
into two groups with the general charac-
teristics of Lee (1940) and Bon (1943) 
viruses. 
In 1946-47 there appeared to be a 
major shift in antigenic constitution when 
the FM 1 (1947) type virus was dis-
covered. Thus, this virus and the FW-1-
50 type discovered in 1950 were desig-
nated the A - prime group. 
Studies of the antigenic vanattons 
among influenza viruses are of import-
ance not only for the better understand-
ing of the epidemiology of the disease, 
but also for problems associated with the 
procuring of an effective vaccine against 
it. It has been clearly established that a 
vaccine made from the strains which dif-
fered considerably from the epidemic 
strain in question, did not protect against 
the disease. However, minor variations 
may not influence the effectiveness of the 
vaccine too much. 
The mechanism responsible for the 
changes in the antigenic pattern of in-
fluenza virus cannot be satisfactorily ex-
plained at present. One theory is that 
influenza viruses are constantly mutating 
and that entirely new antigenic types ap-
pear occasionally. Another theory states 
that influenza viruses contain a large but 
finite number of antigenic components 
which may be present in different com-
binations and proportions. Changes in 
antigenic pattern may be the result of 
selection or rearrangement induced by 
environmental factors such as passage 1n 
partially immune human hosts. 
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CLINICAL ASPECTS 
The exact mode of transference of in-
fluenza from man to man is unknown, 
but is presumed to be by the inhalation 
of infected droplets, discharged into the 
air during the process of talking, cough-
ing and sneezing. 
The incubation period lasts from 24-72 
hours and terminates in a sudden onset 
of illness with headache and/or shiver-
ing. Sometimes a vague onset occurs 
after premonitory symptoms of cough, 
so re throat or a cold. More often the 
patients can tell the hour of onset by a 
sudden backache or headache or sneezing. 
Rarely, ,a fainting spell may be the ini-
tial symptom. Following the initial symp-
toms, the patient usually recognizes a 
rapid worsening of his condition with 
headache, anorexia, prostration and mus-
cular aching. The symptoms all tend to 
be more severe in the older age group. 
The temperature rises sharply to a peak 
and thereafter may decrease slowly or 
become totally irregular. The duration 
of fever averages 72 hours but may 
last only 48 hours. Once the tem-
perature has reached its peak, constitu-
tional symptoms diminish and symp-
toms arising from the respiratory tract 
become more prominent. The nose is 
either running or blocked ; cough is in-
variable but sputum is raised in less than 
one-third of uncomplicated cases. Sore 
throat and hoarseness occur in about one-
half of cases. Chest pain, usually sub-
sternal in location, is felt in about one-
quarter of the patients. Throughout the 
fever, there may be continuing headache 
or muscular pains, anorexia and nausea 
may be present, and sleep is disturbed. 
According to Stuart-Harris, influenza 
virus infection can be accompanied by 
nausea and vomiting, particularly at the 
onset of the disease, but persistent vom-
iting and diarrhea is exceptional. He 
states that epidemics of nausea and vomit-
63 
-----Influenza--------------------------------------~ 
ing must be due to an entirely different 
agent or group of agents. 
Confusion between influenza and the 
onset of encephalitis lethargica and polio-
myelitis probably accounts for the occa-
sional "nervous" forms of influenza, al-
though a mutant strain of influenza virus 
with neurotropic properties has been pro-
duced in the laboratory. 
Characteristically the patient gives the 
appearance of extreme weariness and has 
no desire to interest himself in any activi-
ty other than sleep. There is flushing of 
the face at the height of the fever and 
slight cyanosis of the lips may be evident. 
Apart from the general appearance of 
the patient and physical signs in the res-
piratory system, the signs are few. The 
eyes often show slight lacrymation and 
the conjunctivae are mildly suffused. The 
nose is not so much afflicted by discharge 
as by being blocked and dry. The pharynx 
appears normal in some cases. In others 
it is injected, with prominent vessels an·d 
swollen adenoid tissue, and in a few pa-
tients a dry granular appearance of the 
pharyngeal wall may be seen. Cervical 
adenitis is not prominent, though tonsil-
lar glands may be slightly swollen. The 
voice is often affected, but actual aphonia 
is rare. 
The chest often is clear of physical 
signs throughout the illness, but in about 
one-third of uncomplicated cases there 
are a few loose rales or scattered rhonchi 
which soon clear up. In such patients 
there may be a productive cough with 
greenish mucopus. In general, however, 
the cough is dry. The pulse varies greatly, 
tachycardia being more common during 
the acute phase, and bradycardia in con-
valescence. 
The tongue is frequently coated but 
the abdomen is normal. Albuminuria is 
not more than that associated with any 
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fever. Slight leukopenia IS more com-
mon than leukocytosis. 
DIAGNOSIS 
The diagnosis of a case of influenza 
can most often be made by the appear-
ance of the typical clinical picture occur-
ring during an epidemic. A diagnosis of 
influenza between epidemics should be 
made with caution. Ordinary lab tests are 
of little use in establishing a diagnosis. 
The finding of leukocytosis usually indi-
cates the presence of a bacterial compli-
cation. The sed rate is slightly elevated 
during convalescence. 
The positive diagnosis of influenza 
virus infection depends upon the inves-
tigation of individual patients by attempts 
to recover influenza virus from their 
secretions, or by tests for antibodies in 
their sera. 
Ferret innoculation has been used to 
demonstrate the influenza virus, but it is 
now practised chiefly as a method for 
the production of immune convalescent 
serum. 
The most common method used to re-
cover the virus is as follows: suspected 
patients gargle with a sterile broth-saline 
mixture, preferably within the first two 
days of illness, and deposit the fluid into 
a sterile container. Antibiotics are added 
to the specimen to kill bacteria and 0.2 
ml. of treated garglings is injected 
amniotically into fertile hens' eggs previ-
ously incubated for 13 days. These eggs 
are then incubated again for four days, 
at which time the amniotic fluid is col-
lected and mixed with a 1% suspension 
of each fowl and guinea-pig red blood 
cells. Red-cell agglutination at dilutions 
of 1:10 to 1:160 indicates influenza virus 
infection. Proof that hemagglutination is 
due to influenza virus is obtained by titra-
tion of positive fluids against immune 
sera which inhibit specifically influenza 
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virus A or virus B hemagglutination. Also, 
antigens can be prepared from the amni-
otic membrane and tested against specific 
sera by the complement-fixation test. 
In the examination of human sera for 
antibodies, a sample is obtained early in 
the disease and the titre of antibody is 
compared with that in a sample of serum 
obtained during the convalescent stage. 
The sera can be tested by one of three 
different methods; either by examination 
for neutralizing antibodies against living 
virus, which necessitates the use of mice 
or chick embryos, or by in vitro methods, 
namely the hemagglutination or Hirst test 
and the complement-fixation test. Diag-
nosis is based upon the demonstration of 
a four-fold or greater concentration of 
antibody in the convalescent serum com-
pared with that present in the first serum. 
While these complicated laboratory 
tests are used in experimental and epi-
demiological studies, they are impractical 
in the diagnosis of individual cases of 
influenza. 
Influenza must be differentiated from 
psittacosis, Q fever, febrile catarrh, prim-
ary atypical pneumonia and pyrexia of 
unknown origin. Other conditions which 
may onset with influenza-like symptoms 
are pyelitis, enteric fever, tuberculosis, 
brucellosis, subacute bacterial endocar-
ditis, infectious hepatitis, Weil's disease, 
glandular fever, the leukemias, Hodgkin's 
disease and the reticuloses in the earlier 
stages. 
COMPLICATIONS 
The most important complications of in-
fluenza are paranasal sinusitis, otitis media, 
bronchitis, bronchiolitis and pneumonia. 
A certain degree of paranasal sinusitis 
is probably always present but becomes 
serious when widespread bacterial infec-
tion occurs. 
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Otitis media and subsequent mastoiditis 
may occur from extension of the process 
up the Eustachian tubes. 
Influenza! bronchitis is seen at all ages 
but is a serious condition only in the 
elderly or those already afflicted by some 
chronic cardiac or respiratory disease. 
Mucopurulent bronchitis is suspected 
when the initial dry cough of influenza 
becomes productive and is accompanied 
by signs in the chest such as generalized 
rhonchi or sneezing, and mild dyspnea. 
It varies in severity and usually clears up 
promptly in patients with previously 
healthy lungs, once the temperature is 
normal. 
Bronchiolitis is suspected if the tem-
perature remains elevated on the third 
day or subsequently if the patient coughs 
frequently and has mucopurulent sputum, 
and if examination of the chest reveals 
patches of fine rales at one or both lung 
bases. Such patients become mildly dys-
pneic but do not complain of pleural 
pain. X-rays of the chest may either re-
veal no abnormality or else show increased 
bronchial markings. Recovery, even with-
out antibiotics, is usual. If, however, the 
patient has pre-existing disease such as 
bronchiectasis, emphysema, or congestive 
heart disease, bronchiolitis may cause 
death. 
Influenza! bronchitis and bronchiolitis 
are related to influenza virus infection, 
but are also accompanied by invasion with 
pathogenic nasopharyngeal bacteria. A 
preponderance of Hemophilus influenzae 
is found in the most seriously affected 
patients. 
Influenza! pneumonia with accompany-
ing consolidation may develop during the 
course of the febrile phase of influenza 
or may follow after the patient bas made 
an apparent recovery from the primary 
infection. A pneumonic process is sus-
pected when the convalescing pa·tient 
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again becomes febrile and complains of 
cough, dyspnea, and pleural pain. Sputum, 
which may be mucopurulent, purulent, 
or frankly bloodstained, is usually evident 
at this stage. Physical signs in the chest 
are those of frank consolidation with dull-
ness, often suggestive of a small effusion, 
bronchial breathing, and abundant rales. 
Rales may also be evident in other areas 
where dullness cannot be elicited. X-ray 
of the chest usually shows scattered areas 
of relatively dense opacity resembling a 
bronchopneumonia. 
During the great pandemic, fulminant 
influenza! pneumonia was often seen. It 
is characterized by the rapid development 
of extreme dyspnea and prostration in 
an apparently simple case of influenza. 
Within a matter of hours, the patient is 
dangerously ill and presents a shocked ap-
pearance, with livid or heliotrope cya-
nosis, sweating, tachycardia, and a low 
blood pressure. The temperature, which 
may be high initially, falls steadily and 
may be subnormal at the time of admis-
sion. Cough and sputum may be absent, 
but in some patients there is a frequent, 
ineffective cough, raising only a little 
frothy or bloodstained sputum. Physical 
signs in the chest are: numerous wide-
spread rales and weak breath sounds; 
dullness is usually absent. As the illness 
progresses, there are bouts of extreme 
dyspnea with great restlessness. The 
mentality is usually lucid until death, 
which often occurs within 48 hours. If 
the patient survives, the typical picture 
of consolidation appears. 
All fatal cases of influenza, except pos-
sibly some of those in the aged or en-
feebled are attributable to bacteriological 
action. Pneumococci predominate in the 
sputa of patients who develop pneumonia 
some days after the onset of influenza. 
Pyogenic staphylococci occur in a Jesser 
percentage of cases, but particularly in 
cases concurrent in time with the influ-
enza virus infection. Occasionally hemo-
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lytic streptococci or Klebsiella pneumonia 
are the invading organisms. 
It is debatable to what extent · the in-
fluenza virus is responsible for influenza} 
pneumonia and how much is due to bac-
terial invasion. Some authors believe that 
the virus infection is limited to the 
pharynx, and others think that it is re-
sponsible for the epithelial lesions of the 
trachea and bronchi. It is unlikely, ex-
cept in cases of severe and fulminant 
pneumonia, that the virus plays a role in 
continuing pulmonary infection, and thus 
treatment directed towards the bacterial 
component is usually adequate. However, 
the virulent virus of 1918 probably had 
definite pneumotropic properties. 
PATHOLOGY 
No one has convincingly demonstrated 
that influenza virus unaccompanied by 
bacterial superinfection will produce a 
necrotic epithelial reaction in the trachea 
or bronchioles in man, so that patho-
logical reports are confusing. The char-
acteristic feature most often described is 
a necrotising process of the surface cili-
ated columnar epithelium of the trachea 
and bronchioles. 
In Staphylococcal influenza! infection, 
the entire bronchial mucosa is converted 
into a mass of fibrin enmeshing necrotic 
cells and leucocytes, and resembling gran-
ulation tissue. The lung itself shows 
edema fluid and intense congestion, with 
alveoli choked with red cells, or else an 
organizing exudate of polymorphonu-
clear cells. Actual focal abscesses may be 
found. Exudate and swelling bronchiolar 
epithelium often leads to obstruction and 
atelectasis of the alveoli . 
In mild cases of influenza, a diffuse in-
flammation of the respiratory tract from 
the nasopharynx to the bronchioles is 
usually found . 
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EPIDEMIOLOGY 
Epidemics of influenza occur in winter 
or early spring and are characterized by 
their explosive spread. They usually reach 
a peak in 2 to 3 weeks and subside grad-
ually over a period of 4 to 8 weeks. 
Influenza A epidemics in America occur 
at intervals of 2 to 3 years and influenza 
B at intervals of 4 to 6 years. Therefore, 
it would seem that immunity is of rela-
tively short duration. Most of the popu-
lation become immune during an epidemic 
either by illness or subclinical infection. 
This immunity reaches a maximum in 2 
to 3 weeks and is responsible for the grad-
ual subsidence of the epidemic. 
Several theories have been evolved as 
to the origin and spread of epidemics. 
The first, or latent virus theory, is that 
the virus "goes underground" at the end 
of a period of epidemic prevalence. It 
exists in some form of latent infection, 
perhaps in some remote corner of the 
respiratory tract, or in an animal reser-
voir, in which state it cannot be detected 
by normal methods of investigation. This 
theory postulates that at a certain time, 
when conditions are ripe, the latent in-
fection becomes manifest and spreads 
through the susceptible population. 
The second theory concerning the per-
sistence and spread of human influenza 
is that the virus exists by a continual 
case-to-case transmission. This pre-sup-
poses that there is always an outbreak of 
influenza somewhere in the world, and 
that as influenza dies out in one country, 
it develops anew in another area. The 
alteration between the winter seasons in 
the Northern and Southern hemispheres 
furnishes a possible mechanism for the 
continuous survival of virus, as also do 
studies of the spread of epidemics from 
one country to another. 
No one can say which of these two 
modes of survival is the method adopted 
MAY, 1955 
by the virus, but it is dear that global 
study of influenza epidemiology is the 
only way to solve the problem of the 
origin of the epidemic. 
VACONATION 
The initial studies on vaccination of 
human subjects with influenza virus were 
undertaken to determine whether the ad-
ministration to man of active virus by the 
subcutaneous or intracutaneous routes 
would incite infection, and in order to 
gain evidence of the degree of antibody 
response which could be elicited. Utiliz-
ing the PR 8 strain of type A virus, it 
was found that virus propagated in chick 
embryos given by either route, did result 
in the production of neutralizing anti-
bodies to titres comparable with those of 
convalescent patients. The peak was 
reached in the second week, and a rela-
tively high level persisted during a period 
of 6 months. 
In 1936 Stokes and Shaw reported an 
incidence of febrile illness in 2.7% of a 
g roup of children innoculated ~ith a 
mouselung suspension of human virus A, 
and 12.5% in a control group, during an 
influenza epidemic. Further controlled 
studies were carried out over the next 
few years, but there was little consistent 
evidence that subcutaneous vaccination 
afforded effective protection against in-
fluenza in times of epidemics. It was 
thought that if influenza was not pre-
vented in the vaccinated individuals it was 
because (a) the vaccine was not of suffi-
cient potency to excite antibodies to uni-
formly adequate levels, (b) the strains in 
the vaccine were not sufficiently similar 
to those causing the epidemic, or (c) the 
level of antibodies in the blood, resulting 
from vaccination, was not sufficiently 
high to control influenza. 
In 1940, Hirst, Rickard, Whitman and 
Horsfall carried out a study comparing 
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the effects of more concentrated vaccines. 
They found with active influenza virus, 
that the antibody titres attained increased 
as the amount of virus in the innoculum 
increased. A tenfold concentration of A 
virus and a fourfold concentration of B 
virus was suggested as optimal. In 1942, 
two groups of investigators demonstrated 
that virus could be concentrated from 
allantoic fluid by freezing and then thaw-
ing at a low temperature. This concen-
trated vaccine, when inactivated, induced 
better antibody responses than had been 
obtained with unconcentrated vaccine, and 
as good as those with active centrifugal 
material. From 1942-45 extensive studies 
using the new concentrated inactivated 
vaccine were carried out at Cornell Uni-
versity, University of Michigan, Yale, and 
Alabama in the U.S.A., Glasgow, Scotland, 
and Woolwich, England. All the results 
were definitely in favour of the vaccine. 
After a lapse of three years from the 
influenza A epidemic of 1943, an out-
break of the disease was anticipated in 
the winter of 1946-47. At the end of 
October, 1946, a vaccination study was 
again instituted at t he University of 
Michigan and 10,328 persons received 
vaccine containing the same strains as in 
previous years. 7,615 were unvaccinated. 
When influenza occurred in March 1947, 
no evidence of protective effect was dem-
onstrated in the immunized group. Here, 
the incidence was 7.19% as compared 
with 8.09% in the control group. It was 
apparent that a new virus strain had ap-
peared and that the antibodies produced 
by the old strain were not effective against 
it. That the new strain was of type A, 
was shown by the fact that the majority 
of convalescent patients exhibited an anti-
body rise to PR 8 or to other A strains 
as proved by hemagglutination-inhibi-
tion and other tests. The new antigenic 
variant was designated A prime, FM 1 
(1947) and the Commission on Influ-
enza recommended that it be incorporated 
into subsequent vaccines. 
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Studies over the next three winters 
proved the efficacy of the new FM 1 vac-
cine. Epidemics in the years following 
1947 have shown a prevalence of A-prime 
influenza infection, and recent studies 
using only A-prime strains indicate a 
high degree of protection, although the 
epidemic strain may differ serologically 
from that of the vacc·ine. 
The accumulated evidence with epi-
demics caused by the A-prime strains has 
shown that protection can be obtained by 
the use of vaccine strains which are not 
identical with those prevalent. This is 
important with regard to both cross-
immunity and antigenic composition. 
A number of early studies suggested 
the possibility of using lipids to enhance 
the antigenic activity of influenza virus. 
Recently Salk and his associates have con-
ducted extensive investigations of the use 
of virus first emulsified in mannide mono-
oleate, and then suspended in a light 
mineral oil. The titres obtained with 
these adjuvant vaccines greatly exceed 
those obtained with similar amounts of 
virus in aqueous vaccine, and also the cost 
of its production is considerably less than 
that of aqueous vaccine. 
Vaccination against influenza has been 
shown to be uniformly effective under a 
variety of conditions when vaccines of 
proper constitution and potency are em-
ployed. Although epidemological and 
serological data have indicated the prob-
ability that strain differences are import-
ant in the recurrences of influenza, the 
degree of variation so far observed is a 
limited one, representing more of a re-
arrangement of viral components than 
complete loss or gain of basic constitu-
ents. Francis states that current analyses 
strongly support the concept that the 
antigenic constitution of influenza virus 
of a particular type can be mapped. It 
is the expectation, then, that vaccine can 
be so composed as to contain the differ-
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ent antigenic components required, and 
will induce the broad resistance which 
otherwise is acquired only by repeated 
exposures to the disease. There remains 
the problem of virulence, but most of 
the data indicate that even highly viru-
lent strains can be counteracted by ade-
quate vaccination or by infection with 
mild strains. Moreover, relatively new 
antigenic strains are not necessarily high-
ly virulent as evidenced by the mild char-
acter of A-prime strains in 1946-47. 
In conclusion, the outlook for increas-
ingly broad prophylactic immunization 
against the range of influenza viruses is 
extremely promising. 
TREATMENf 
There is no specific treatment for in-
fluenza virus infect,ion. The only answer 
at the present time appears to be pro-
phylactic immunization, but since recent 
influenza epidemics have been so mild, 
and since the immunity conferred by avail-
able vaccines only lasts about six months, 
this would seem -impractical. 
Influenza patients should be isolated 
during the febrile stage of the illness. 
This is not so much to prevent the spread 
of the epidemic as to protect the patient 
from bacterial contamination while his 
respiratory tract is in such a susceptible 
state. Bed rest is advocated in a warm, 
humid room. Aspirin every four hours 
until symptoms subside is probably the 
best medication. Other symtomatic mea-
sures are: an icecap for headache, mas-
sage and alcohol rubs for myalgia, a sooth-
ing cough mixture or steam inhalations 
for the dry cough, and a barbiturate for 
insomnia. 
Patients should have a high fluid in-
take to replace fluid lost by sweating, and 
a light wholesome diet during the acute 
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phase of the illness. Good nursing care, 
and reassurance of the short duration of 
the condition are very important. 
The patient should be kept in bed un-
til at least one day after the pyrexia has 
disappeared, and a more prolonged bed-
rest is needed if there is continued cough 
and expectoration, or in elderly subjects. 
In any case, cough should have dis-
appeared before normal activities are re-
sumed, and additional care should be 
exercised in any subjects with previous 
chronic chest disease. 
The question which is often raised, is 
whether routine use of chemotherapeutic 
agents would diminish the risk of second-
ary bacterial infections of the bronchi or 
lungs after influenza. There is no cer-
tain knowledge that chemo-prophylaxis 
would be effective, and the risk of such 
possible complications is small. Chemo-
prophylaxis should therefore be reserved 
for patients in the older age-groups or 
with previous chest disease, such as 
chronic bronchi,tis or bronchiectasis, par-
ticularly if persistent signs in the chest 
are still present by the third day of in-
fluenza. Influenza in subjects with chronic 
heart disease should also be considered 
as an indication for chemo-prophylaxis. 
With the onset of severe bronchiolitis 
or pneumonia, adequate dosage of appro-
priate antibiotics should be given at once. 
CONCLUSION 
In this paper, the various aspects of 
influenza and its complications have been 
discussed in an attempt to clarify the con-
fusing Flu symptom-complex. Although 
mortality due to influenza is declining, it 
is still a serious cause of morbidity. The 
ultimate control of the disease depends 
upon the discovery of a vaccine which 
will confer long-lasting immunity against 
all strains of the influenza virus. 
Hepatic Coma 
Velta J. Cemavskis, '55 
INTRODUCTION 
Hepatic coma is a form of disturbed or impaired consciousness which may 
be observed in the course of liver disease. 
This condition, however, is not the only disorder which may be associated 
with the downhill course of hepatic disease. The generally debilitated patients 
are 'Susceptible to infection. Cirrhosis leads to hypoglycemic attacks. Wernicke-
Korsakoff syndrome and delirium tremens can be associated with liver disease 
and give rise to neurological symptoms if chronic alcoholism happens to be the 
cause of cirrhosis. 
Even death following liver disease is not always preceded by hepatic coma. 
According to Lichtman, terminal liver disease may take three courses: 
(I) the patient succumbs due to infection of liver or biliary passages with 
its accompanying toxemia; 
(2) hepatic involvement leads to chronic portal stasis, recurring ascites, fail-
ing nutrition, and toxemia which are the causes of death; 
(3) the patient may die in hepatic coma. 
This paper will discuss hepatic coma- " the tragedy of the last act of liver 
disease" as Eppinger called it. An attempt will be made to outline the course of 
events associated with this condition, and to give the changing thoughts on patho-
genesis and management. 
IDSTORY 
Since early times central nervous sys-
tem changes during the course of liver 
disease have been observed. Galen had 
referred to it in his writing: ". . . bills 
ad caput recurrens delirii causa" - jaun-
dice is the cause of recurring delirium. 
Franciscus Ruboeus (1"660) is credited 
with the earliest description of acute yel-
low atrophy. Morgagni (1761) collected 
classic descriptions of the fatal delirium 
associated with liver disease from the 
writings of Baillou, Guarinonius, and Val-
salva which showed jaundice followed by 
coma and death. Griffin (1834), Bright 
(1836), and Budd (1845) also described 
acute fatal jaundice with mental and 
neurological changes. Bright's description 
included such typical signs and symptoms 
of hepatic coma as dilatation of the 
pupil, irregular jerky movements of the 
limbs, flexion of knees against abdominal 
wall, difficulty of articulation, and attacks 
of screaming followed by coma and death. 
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Frerichs, who recognized the gravity of 
delirium as a symptom of jaundice and 
analyzed the symptom-complex in 31 cases 
of acute liver failure, is said ·to be the 
father of modern study of liver disease. 
Since then many men have contributed 
to the description and understanding of 
the condition, but a complete historical 
account is outside the scope of this paper. 
ETIOLOGY AND INCIDENCE 
Any type of hepatic disease may lead 
to hepatic coma. All these underlying con-
ditions, however, may be divided into two 
large groups: 
(1) acute yellow atrophy 
(2) chronic liver disease 
By acute yellow atrophy is meant any 
severe form of hepatitis due to many un-
related causes characterized by extreme, 
progressive disturbance of the liver func-
tion. These cases usually run a short 
course, terminating in coma. 
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When the coma is superimposed on 
chronic liver disease such as portal or 
biliary cirrhosis, carcinoma of liver, or the 
Budd-Chiari syndrome, the course of the 
disease is usually not so fulminant, and 
often some precipitating factors are held 
responsible for the patient's lapse into 
coma. In these cases infections, hemor-
rhages, repeated paracenteces, high pro-
tein diet, ammonia-containing compounds, 
morphine, demerol, barbiturates, paralde-
hyde, anoxia, shock from any cause, and 
surgical procedures are known as coma-
precipitating factors. Of course, all these 
factors may also add to the gravity of 
coma when it has developed on the basis 
of acute yellow atrophy. 
In surveying the literature no reliable 
figures on the incidence of hepatic coma 
were found because few large series have 
been studied. There were 11 cases of 
hepatic coma in one year at the Phila-
delphia General Hospital. The incidence 
of coma in cases of cirrhosis has been 
given as from 16 to 42% in different 
series of cases studied. Children may be 
affected, as well as adults, and in children 
coma usually bears a graver prognosis 
than in adults. 
CLINICAL PICI'URE 
Adams and Foley {1949) described the 
clinical syndrome of impending coma. 
The signs and symptoms are largely neuro-
logical and may be described under three 
headings: changes in mental status; char-
acteristic tremor; electroencephalographic 
changes. 
All mental processes are slowed. The 
patient is drowsy, apathetic, and lethargic. 
With increased clouding of consciousness 
the ability to perform coordinated move-
ments skillfully is lost. The patient may 
become disorientated, confused, or quite 
often restless, agitated, and irritable be-
fore the stupor deepens into coma. Despite 
all these symptoms the patient may main-
tain that he feels well. 
The characteristic tremor is best seen when 
the patient holds his arms forward with 
hands and fingers extended. Coarse ir-
regular flexion-extension movements of 
the fingers and wrists are seen which 
have been described as having "flapping" 
quality. Occasionally the tremor involves 
even upper and lower extremities, and 
facial muscles. 
Not all patients with impending 
hepatic coma exhibit electroencephalographic 
chattges. Some degree of slowing of waves 
may be associated with disturbance of con-
sciousness from any cause. But in this 
c~ndition, bursts of bilaterally synchron-
ous slow waves about 2 to 3 per sec. alter-
nate with intervals of normal activity. As 
the coma deepens the slow waves persist 
throughout the tracing, spreading from 
frontal areas where they make their first 
appearance to other areas. If not pathog-
nomonic typical triphasic waves are said 
to be extremely suggestive of hepatic 
coma. The frequency of waves is the 
same from patient to patient, and in the 
same patient at different times. The dis-
tribution and severity of EEG changes 
are roughly related to the severity of 
coma. 
The patient may recover from impend-
ing coma or progress to coma. 
The patient, having passed through the 
excitable stage of moaning and groaning, 
appears to be asleep, and resembles a pa-
tient under deep anesthesia with quiet and 
regular breathing, responding to very few 
stimuli . He can be aroused at first to a 
drowsy and stuporous state. 
The neurological signs present a com-
plex picture of involvement of cortex, 
pyramidal tract, and basal ganglia. Walshe 
observed the following signs in 18 cases 
he studied: 
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"personality changes, mania and coma, 
with dilated pupils, choreiform move-
ments of the arms, tonic grasping, and 
sometimes lead-pipe and cogwheel rig-
idity; absent abdominal reflexes, in-
creased knee jerks, ankle clonus, and 
extensor plantar responses. In some 
patients there was either spasticity or 
lead-pipe rigidity of legs. During the 
early phase of coma, patients some-
times adopted a characteristic posture 
with the legs tightly drawn up against 
the abdominal wall. Cranial nerve pal-
sies were rare, convulsions were not 
observed. All changes were more promi-
nent in children than in adults." 
Loss of consciousness was the only single 
feature common to all the cases of hepatic 
coma W alshe studied. Pyramidal signs 
were the next most commonly observed 
neurological abnormality. Usually in later 
stages of deep coma the positive signs 
of pyramidal involvement disappear and 
the extremities may vary from extreme 
rigidity to flaccidity. Convulsions are not 
a characteristic feature of hepatic coma. 
They may occasionally precede death, 
however. 
Fetor hepaticus which refers to the 
characteristic odour on the breath and in 
the urine of the patients is found in near-
ly all cases. But it is said to be also pres-
ent in the urine of normal persons. The 
causative factor of fetor hepaticus is un-
known; many speculations have been made 
in the past as to whether this unknown 
factor might play a role in initiating 
hepatic coma. 
Temperature and pulse are usually 
slightly elevated. Bleeding is common be-
cause the hepatocellular damage interferes 
with prothrombin formation. Other signs 
and symptoms are those due to the under-
lying liver disease. The clinical picture 
may present itself in a variety of forms. 
There are no constant abnormal findings. 
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PROGNOSIS 
Hepatic coma is a reversible condition, 
but once coma has occurred the course 
of the disease is unpredictable. Sborov 
states that 60% of his patients at Wash-
ington, D.C., were awakened from coma, 
but only 25 % recovered long enough to 
be discharged from the hospital. Prog-
nosis is much poorer when coma com-
plicates acute hepatitis than when it is 
superimposed on chronic liver disease. 
The hepatic necrosis progresses so rap-
idly that the "point of no return" is often 
reached with the onset of coma. 
The longer the coma persists, the 
poorer is the prognosis. Sborov gives 45 
days as the longest known duration of 
coma terminating in death, and 12 days 
as the longest coma before recovery. 
CLINICAL INVESTIGATION 
(1) Cerebrospinal Fluid 
Cerebrospinal fluid pressure is not 
elevated in hepatic coma. Bilirubin of the 
direct reacting variety and xanthochromia 
have been found in the cerebrospinal fluid 
of jaundiced patients in coma, but there 
is no correlation between the degree of 
hyperbilirubinemia and the amount of 
bilirubin in the spinal fluid. An increase 
of cerebrospinal fluid protein has been 
reported, the significance of which is not 
clear. 
(2) Blood 
The findings of electrolyte disturbances 
are not consistent. Some investigators 
find that the electrolyte levels are essen-
tially normal, though on the low side 
occasionally. Others find altered electro-
lyte patterns: hypokalemia and lowered 
level of magnesia in the blood. Still others 
find low serum sodium and phosphorus 
or chloride levels. But this disturbance 
of the electrolyte pattern may be the re-
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suit of the underlying liver disease because 
in alcoholic cirrhosis the dietary intake 
is poor, and in hepatitis there is anorexia 
and diarrhea. 
Frequently a mild metabolic acidosis is 
observed both in impending and deep 
coma. Moderate hepatic injury may give 
rise to elevation of ketoglutaric acid in 
the blood. Pyruvic acid is increased only 
in the presence of severe hepatic coma. 
Lactic acid is also increased. The increase 
of blood pyruvate is not specific for 
hepatic coma; it is also increased in star-
vation, nutritional deficiency (especially 
thiamine deficiency) , periods of fever, 
physical exercise, and large infusions of 
glucose. Blood lactate is also increased 
in many unrelated conditions. 
Chromatographic studies have shown 
that there is a marked increase in the con-
centration of the amino acids glutamine, 
cysteine, and methionine in the blood. 
Blood ammonia is frequently elevated. 
Schwartz and his colleagues investigated 
the ammonia patterns of 20 patients with 
advanced cirrhosis of the liver who died 
in hepatic coma at the Boston City Hos-
pital. Ammonia was expressed as micro-
grams of ammonia N per millilitre of 
whole blood, which represents free 
ammonia as well as nitrogenous sub-
stances in the blood capable of releasing 
ammonia. 
Mean 
Value Range 
Normal ... .. ... ... ... ... .... . 2.04 1.0-3.0 
Cirrhosis . 2.74 
Impending coma ... 4.32 2.0-10.0 
Coma 6.0 2.0-15.4 
The individual values ranged from 
normal to highly elevated. Despite the 
higher ammonia levels in impending and 
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deep coma in his observations neither 
tremor nor state of consciousness corre-
lated completely with blood ammonia 
values. This has also been confirmed by 
other investigators. The highest level was 
found in a patient who was subjectively 
well and working. 
Hemoglobin may be significantly de-
creased. It usually correlates well with 
the degree of hepatocellular fairure or 
bleeding. Leukocytosis and an absolute 
increase in polymorphonuclear leukocytes 
are often observed in hepatic disease. 
Blood sugar is usually maintained at 
the normal level, though hypoglycemia or 
hyperglycemia have been reported occa-
sionally. Hypoglycemia may give rise to 
neurological symptoms which have to be 
differentiated from those usually occur-
ring in hepatic coma. Azotemia is usually 
not a part of the picture. Sometimes blood 
urea N is elevated terminally. 
(3) Liver Function Tests 
In the cases Carfagno studied at the 
Philadelphia General Hospital, serum 
bilirubin was increased in all. The val-
ues varied between 1.85 - 30.0 mgm per 
100 cc. Serum proteins varied from 5.0 
to 7.6 grams per 100 cc. The cephalin 
cholesterol flocculation and thymol tur-
bidity tests were positive. 
Prothrombin concentration does not de-
pend only on hepatic factors, but its de-
crease reflects the degree of liver involve-
ment, and failure of response to paren-
teral administration of vitamin K is a 
poor prognostic sign. 
There is no liver test, however, which 
will indicate the advent of coma. When 
the results of hepatic tests in impending 
coma and coma are compared, there is no 
difference of a sufficient degree to ex-
plain the change in the physical status. 
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PATHOLOGICAL LESIONS 
Since the times of Rokitansky it has 
been known that there are no characteris-
tic changes in the central nervous system 
to account · for the diffuse nervous in-
volvement. Foley reported hyperplasia of 
protoplasmic astrocytes in lenticular, den-
tate and other nuclei, but these changes 
are hard to correlate with the clinical 
find ings. Watson suggested perivascular 
encephalopathy, but the general opinion 
seems to be that the changes in the brain 
are non specific: edema of the brain, con-
gestion of vessels, perivascular mononu-
clear infiltration and minute focal hem-
orrhages throughout t he brain. 
. Hepatic coma is not synonymous with 
hepatic necrosis, though necrosis has been 
frequently found superimposed on the un-
derlying hepatic lesions which precede 
development of coma. Malcolm H. Mac-
donald reviewed eight cases recently dying 
from hepatic coma in Toronto General 
Hospital. He found that in addition to 
their chronic liver changes, they showed 
acute lesions ranging from cloudy swell-
ing to centrolobular necrosis. Vigorous 
regeneration of liver tissue has occasion-
ally been noted ; these regenerating liver 
lobules may or may not be involved by 
necrosis. Other patients with cirrhotic 
livers died in hepatic coma, and no 
necrosis is found at autopsy. 
No specific renal lesion has been found 
to account for the oliguria and anuria 
that a certain number of patients develop 
terminally. The kidneys show either bile 
nephrosis, lower nephron nephrosis, or 
intercapillary glomerulonephritis. 
PATHOGENESIS 
About 120 years ago Dr. Griffin 
described four cases of jaundice in which 
the patients went into coma. He asked 
at that time, "On what morbid state would 
occurrence of coma in these particular in-
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stances depend?" This question has not 
yet been satisfactorily answered. 
According to Walshe, any theory which 
attempts to account for the pathogenesis 
has to explain the following features of 
hepatic coma: 
(I) the reversibility of all signs and 
symptoms; 
(2) the variations in the clinical pic-
ture and reflex changes from day 
to day, and from case to case; 
(3) the absence of significant morpho-
logical changes in the brain ; 
( 4) the lack of consistency in the 
laboratory findings; 
(5) the occurrence of a clinically in-
distinguishable coma in acute he-
patic necrosis and chronic liver 
disease. 
Frerichs (1860) originated the theory 
that toxic breakdown products of necrotic 
liver tissue damage the brain cells. Other 
theories tried to explain the symptoms on 
the basis of disturbed carbohydrate metab-
olism due to hypoglycemia or faulty in-
corporation of pyruvic acid in the Krebs 
citric acid cycle; decreased plasma choli-
nesterase activity leading to acetylcholine 
accumulation ; and toxicity of amino acid 
imbalance. If hypoglycemia or acetylcho-
line were the causative factors they would 
lead to convulsions, but convulsions are 
rare in hepatic coma. In addition, hypo-
glycemia itself is rare in this condition, 
and correction of it does not produce im-
provement in the clinical status. Also no 
improvement is shown when the low 
plasma cholinesterase activity is corrected 
by administering plasma cholinesterase 
concentrate. It was mentioned previously 
that increased pyruvate in the blood is 
also observed in other conditions and is 
not specific for hepatic coma. 
Cholemia has been largely discarded as 
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a factor in the production of coma as it 
was shown that complete biliary obstruc-
tion is fatal, but does not produce coma, 
and coma may be superimposed on liver 
disease when there is only a slight bile 
retention . 
Recent work has centered around an 
inefficient ammonia binding mechanism. 
It was in 1927 that Burchi first noted 
raised blood ammonia levels in cirrhosis 
of the liver. Van Caulaert and Deviller 
(1932), and Field (1939) observed drow-
siness, coma, and delirium after the ad-
ministration of ammonium salts in patients 
with cirrhosis. After observing symptoms 
indistinguishable from hepatic coma on 
administration of nitrogenous substances 
such as ammonium chloride, diammonium 
citrate, urea, and sometimes dietary pro-
tein to some of their cirrhosis patients, 
Phillips et al (1952) again directed the 
attention to blood ammonia as a causa-
tive factor. But as mentioned before, 
blood ammonia is not directly related to 
the degree of consciousness. Cases have 
been reported where the onset of coma 
preceded a significant elevation of blood 
ammonia by twenty-four hours. On sev-
eral occasions blood ammonia was found 
normal on the day of death. 
Walshe (1951) suggested that a high 
level of intracellular ammonia might be 
a possible cause of hepatic coma. Ammonia 
is a n intracellular cation which when 
present in excessive amounts may inter-
fere with normal nerve cell function giv-
ing rise to drowsiness, coma, and death . 
Ammonia is released by deamination pro-
cesses and by breakdown of nitrogenous 
substances by the bacteria in the intestine. 
It is taken then to the liver via the portal 
circulation where its conversion to urea 
takes place. However, when the portal 
circulation bypasses the liver and enters 
the systemic circulation, the ammonia 
level in the blood rises. This takes place 
in cirrhosis of liver and in Eck-fistula 
man and dogs in which there is an estab-
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lished anastomosis between the portal 
vein and the vena cava. Opinions have 
differed as to whether the rise of 
ammonia observed in hepatic coma is due 
only to diversion of portal blood or 
whether liver damage is partly responsible 
for it too. Clinical observations and ex-
perimental evidence seem to suggest that 
bypassing of the liver is the most import-
an t factor. This is shown by the normal 
values of blood ammonia in hepatitis. 
Also administration of protein and nitro-
gen in an Eck-fistula man with a normal 
liver induces the syndrome of impending 
coma. 
It has been shown by Krebs, Quastel 
(1935) and Weil-Malherbe (1936) that 
glutamic acid is the only amino acid to 
support brain respiration in vitro. Weil-
Malherbe (1950) showed that its role in 
supplying energy to the brain is secondary 
to its role in the ammonia binding mech-
anism. Glutamic acid binds ammonia 
forming glutamine. Increased ammonia 
production may require excessive amounts 
of glutamic acid for its detoxification and 
produce hepatic coma by interference with 
respiration of cerebral tissues. Methio-
nine, which is a glutamic acid inhibitor, 
has been found in cerebrospinal fluid of 
patients with hepatic coma. Reversal of 
hepatic coma has occurred on glutamic 
acid administration. 
A notable rise in the glutamine content 
of the brain has been observed immedi-
ately after hepatectomy in animals. The 
content rises to 4 or 5 times normal in 
24 hours. The absorption of blood gluta-
mine and its transport to the brain was 
prevented by injections of large amounts 
of insulin in glucose, but the rise of gluta-
mine in spinal fluid continued. What 
roles glutamine and intracellular ammonia 
play in initiating the coma is not yet 
known, but there seems to be at least 
some relationship. One must remember 
that changes in peripheral blood ammonia 
levels are only a rough indication of the 
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ammonia metabolism in brain cells, and 
it would be useful to find some direct 
or indirect measurement of intracellular 
ammonia. 
Singh suggests that at the present time 
the blood ammonia levels in hepatic dam-
age should be regarded in much the same 
light as the blood urea level in chronic 
kidney damage. Neither should be re-
garded as the actual cause of clinical 
symptoms, but a raised level of either 
evidences a grave state of affairs in the 
respective organ. When a patient dies in 
hepatic coma, there are many other fac-
tors which might have contributed to the 
changes in consciousness and to death: 
electrolyte disturbances, bile nephrosis, 
severe respiratory · infections, septicemia, 
etc. 
Methods have been devised to induce 
hepatic failure and coma in dogs on the 
basis of ischemic necrosis of the liver by 
means of the formation of Eck fistula 
and subsequent ligation of the hepatic 
artery. Antibiotics were administered to 
reduce the bacterial factor. Though the 
clinical picture of this experimental coma 
resembles that of man, one cannot draw 
the conclusion that the mechanisms in-
volved are the same. Rappaport and his 
group of workers postulate on the basis 
of these experiments that circulatory fac-
tors may be responsible for the onset of 
and relief of hepatic coma. They main-
tain that the onset of liver failure is pre-
ceded by acute degeneration and swelling 
of liver cells which compress the blood 
vessels producing ischemic necrosis, the 
latter giving rise to some toxic substance 
which may affect the brain cells. Accord-
ing to Rappaport, hepatic ischemia is the 
factor responsible for coma following sur-
gical procedures to relieve portal hyper-
tension in cirrhotic patients. Due to 
cirrhosis most of the portal blood is 
shunted into the systemic circulation pro-
ducing extrahepatic, and perhaps intra-
hepatic, Eck fistulas. When the surgeon 
76 
ligates the hepatic artery he simulates the 
experimental hepatic necrosis produced 
in dogs. 
Widespread destruction of the hepatic 
parenchyma is also associated with a gen-
eral reduction of the multiple hepatic 
functions, and more than once it has been 
said that multiple disturbances of liver 
function should be considered the cause 
of liver coma rather than one single 
factor. 
PRINCIPLES OF MANAGEMENT 
Prevention 
It is difficult to speak of prevention of 
a condition the causative factors of which 
are not known. In a broad sense the ulti-
mate goal would be the prevention of 
liver disease in general. 
It would, however, seem wise to avoid 
those factors which are known to play a 
role in precipitating coma in cases of liver 
disease. Schwartz has described one pa-
tient in whom the rise of dietary protein 
intake from 50 to 75 grams daily was 
sufficient to induce hepatic coma, and 
protein restriction resulted in reversal of 
clinical symptoms and reversal of electro-
encephalographic pattern to normal. Nu-
tritious diets consisting of large amounts 
of protein and carbohydrate are usually 
given to patients with cirrhosis, but 
when impending coma is suspected pro-
tein should be restricted. Each patient's 
tolerance for protein should be indivi-
dually evaluated. Ammonia- containing 
compounds for inducing diuresis or other 
purposes should be avoided. 
As the patient may be delirious, rest-
less, and hallucinated in the early stages 
of impending coma, sedation may seem 
indicated, but it is known that morphine, 
demerol, barbiturates, and paraldehyde 
can precipitate coma. If sedatives are used 
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their potential dangers should be borne 
in mind. 
Although electrolyte disturbances do 
not seem to play a causative role in patho-
genesis, still they may contribute to the 
severity of the illness and, therefore, 
should be corrected if abnormal. Frequent 
paracenteses should be avoided. If done, 
one must realize the changes in electro-
lyte concentration which they cause. 
To avoid hemorrhages an attempt 
should be made to correct the prothrom-
bin level by parenteral vitamin K admin-
istration. However, the response is rarely 
satisfactory because of the severe liver 
damage. 
Infections, anoxia, and shock should be 
avoided . 
Impending or Deep Coma 
It has been said that one should be a 
persistent optimist while treating patients 
with hepatic coma as this is a reversible 
condition. But this same reversibility 
makes it difficult for one to evaluate the 
results of all the treatment schedules 
which have been claimed successful in 
reversing coma. One cannot know which 
cases would recover without any treat-
ment at all. Also the diversity of the 
underlying disease conditions on which 
coma may be superimposed and the un-
known etiological factors add to the com-
plexity of the problem. 
(a) Glttcose, Vitamins, and Electrolytes 
Large amounts of intravenous glucose 
have been rather universally used as was 
recommended by Butt and Snell. They 
gave the daily amount of 3000 to 4000 
cc. containing 50 to 100 mgm. of thia-
mine hydrochloride and 250 to 500 mgm. 
of nicotinic acid. This treatment schedule 
was devised empirically on the assump-
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tion of breakdown of carbohydrate metab-
olism with its associated enzyme systems. 
Attention has been drawn to the fact 
that large amounts of glucose and water, 
if other electrolytes are not corrected, may 
be harmful. This has even been impli-
cated as a factor in causing the so-called 
hepatorenal syndrome. Some authors in-
clude under this syndrome those cases 
where hepatic coma is associated with 
oliguria or anuria. 
Latner developed more elaborate in-
fusions of glucose-saline, plasma, and vita-
mins which he claimed reduced the mor-
tality rate to only 10-20% . He also used 
penicillin to reduce infections. 
The form and amount of glucose used 
depends on clinical judgement. 
(b) Antibiotics 
Aureomycin in doses of 1 gram daily 
by stomach tube has been advised both 
because of its antibacterial action and be-
cause of the role it may play in prevent-
ing hepatic necrosis. Death from hepatic 
necrosis in experimental animals can be 
prevented by giving aureomycin. It has 
been said that this dosage is lower than 
that ·which would cause fatty infiltration 
of the liver and negative nitrogen balance. 
If intravenous therapy is required, the 
intravenous dose of aureomycin should be 
limited to 40 mgm. per kilo of body 
weight per 24 hours. 
Larger doses than those mentioned may 
be used when the potential dangers of an 
excessive dose are outweighed by the 
g ravity of the illness. 
(c) Hormones 
ACTH and cortisone have been advo-
cated. Ducci and Katz noted a spectacu-
lar response to cortisone plus aureomycin 
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and/or intravenous terramycin in two 
young patients who had been in coma for 
over two days. They state that due to 
the prevalence of acute hepatitis in Chile 
they have had a large experience with 
this disease, and in more than a thousand 
cases they had not seen a recovery after 
coma before. They used very high initial 
doses of intramuscular cortisone. In one 
of these patients they used 1500 mgm 
on the first day and 300, 250, and 500 
mgm on the consecutive days; thereafter 
the dose of 100 mgm was used and grad-
ually reduced. 
Others have not met with Ducci's suc-
cess using cortisone, although they fol-
lowed his regime. As in many other 'dis-
eases in which cortisone and ACTH have 
been tried, the results are conflicting. 
Bleeding episodes and water retention 
have been reported after ACTH adminis-
tration . It has also been mentioned that 
ACTH increases blood ammonia. 
The use of cortisone and/or .A.CTH 
seems to be ill advised, especially when 
one takes into consideration the reported 
relapse rate as high as 25 %, frequency of 
side reactions, and fai lure in preventing 
chronic hepatitis. 
(d) Glutamic Acid 
Walshe (1953) used sodium gluamate 
intravenously on the basis of theories as 
outlined previously in five episodes of 
coma in three patients with subacute or 
chronic liver disease. Consciousness re-
turned on all occasions except one when 
glutamate was used together with am-
monia ion exchange resin. In one case 
when glutamate was discontinued, the pa-
tient relapsed into coma which deepened 
on glucose administration, but when gluta-
mate was readministered he regained con-
sciousness. W oodraw has reported suc-
cess with glutamate, also in virus hepa-
titis complicated by coma. 
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Though this type of treatment looks 
very promising, it has not been success-
ful in every case. Riddell and McDermott 
(1954) treated 11 patients, six of whom 
improved on treatment. Three of these 
six recovered from hepatic coma, but only 
one of these left hospital. Two others 
died of intercurrent diseases. Blood am-
monia level fell after administration of 
glutamate in seven patients studied. In 
four of these cases the decrease of blood 
ammonia level resulted in clinical im-
provement. In one case it was shown 
that improvement was only temporary, 
and blood ammonia level became less re-
sponsive to sodium glutamate as the pa-
tient's condition grew worse. 
The value of glutamic acid treatment 
has not yet been established. Riddell 
points out that in patients with terminal 
hepatic failure one cannot expect much 
more than temporary improvement despite 
any treatment used. More success may 
be expected in those cases where the un-
derlying liver disease is not so severe. 
(e) Additional Measttres 
Blood loss should be replaced in cases 
of hemorrhage. As experimental studies 
suggest that oxygen is essential in preven-
tion of further liver damage, it should be 
given. Parenteral vitamin B and K ad-
ministration has been recommended. Some 
have used crude liver extract in addition 
to vitamin B. 
(f) Surgical Treatment 
There is little reference to a surgical 
attack on this condition in the literature. 
Rappaport describes twelve patients suf-
fering from acute yellow atrophy with 
impending coma Pribram and Upham re-
ported, eight of whom recovered within 
twenty-four hours after bile drainage. 
Rappaport, being an exponent of the vas-
cular theory, explains that on removal of 
the stagnant bile the intrahepatic pressure 
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was decreased and blood flow improved. 
The same authors have reported improve-
ment in fourteen cases treated by sympa-
thetic block between the eleventh and 
twelfth dorsal vertebrae. The beneficial 
effects were ascribed to the release of 
arterial spasm which impaired the hepatic 
circulation. Periarterial neurectomy has 
been performed in 17 cases of chronic 
hepatitis with apparently good results. 
Summary 
In summary, the management which has 
proven to be of some value and worth 
clinical trial in patients suffering from 
hepatic coma is as follows: intravenous 
glucose, vitamins B and K, correction of 
electrolyte disturbances, aureomycin, sod-
ium glutamate, blood transfusions, and 
oxygen. 
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together with highly suggestive symp-
toms, signs, laboratory data, and sugges-
tions for further investigation to ascer-
tain the diagnosis. 
As D r. Hyman states in the preface, 
" devised as a complement to, rather t_han 
a substitute for, standard medical texts 
and the living experiences of daily prac-
tice, this Handbook though both accur-
ate and reliable covers, in a selective fash-
ion, the more often encountered medical 
entities and accordingly does not claim 
to be completely inclusive or encyclopedic; 
its context, though thoroughly reliable. 
is far from inclusive; its style, chosen 
for utility rather than for literary merit, 
is not conducive to consecutive reading". 
Here is a text well suited to the stu-
dent in the clinical years who desires to 
acquire a system of orderly and consecu-
tive thought on the differentiation of 
common clinical conditions, and also of 
value to the clinician as a quickly avail-
able and accurate source of reference. 
- Lewis Hersey, '56 
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Severe Infantile Diarrhea 
Alan Rundle, M.D. 
INTRODUCTION 
Fluid and electrolyte loss in an infant can be of sucb severity that their 
restoration to normal often precludes specific therapy in importance. The ex-
planation for this fact lies in the immaturity of renal function and other regula-
tory mechanisms for the maintenance of body fluids. The normal requirements for 
infants of water, electrolytes, protein, calories, and vitamines are relatively greater 
than in adu lts. 
CLINICAL ASSESSMENI' 
A. Dehydration 
(1) sunken fontanelles 
(2) sunken eyes 
(3) soft eyeballs 
( 4) dry mouth and skin 
(5) loss of skin turgor and elasticity 
B. Acidosis 
(1) signs of dehydration 
(2) acetone odour on breath 
(3) respirations deep and sighing, 
or may be shallow 
( 4) lethargic or restless 
( 5) extremities cold and cyanotic 
(shock) 
The most important, and often ignored, 
factor in taking the history is the amount 
of fluid lost. Several small stools may not 
be significant, whereas a few large watery 
stools are a danger sign. 
Dehydration can be very deceiving. A 
child that has been in a good state of 
nutrition prior to illness may not show 
the characteristic signs, but still be ser-
iously dehydrated and even in acidosis. 
Conversely, a child in a poor state of 
nutrition prior to illness will more readily 
and more rapidly demonstrate the classical 
signs and symptoms. 
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LABORATORY ASSESSMENf 
If laboratory procedures are available 
the C02 combining power should be esti-
mated on admission. This test may be 
repeated after star.ting corrective therapy 
to avoid precipitation of an alkalosis and 
to determine the progress of treatment. 
After hydration has been established 
the blood electrolytes should be deter-
mined. Particular attention should be 
placed to the potassium level. This is 
especially important if the replacement 
fluids do not contain that electrolyte. 
EFFECTS OF ELECTROL YfE 
IMBALANCE 
Hypokalemia (low potassium) may be 
manifested by weakness, silent distention 
of the abdomen, dyspnea and cardiac 
signs, including cardiac arrhythmias and 
cardiac failure. Unless care is exercised to 
see that potassium is given this state may 
be precipitated. Potassium may be admin-
istered intravenously in Ringerlactate solu-
tion or in fresh whole blood, or orally 
in potassium chloride. The usual, and 
safe dosage of potassium in infants is 3 
milliequivalents per kilogram per day. 
H yperkalemia, a rare occurrence, may be 
precipitated by continued administration 
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of potassium in the face of poor renal 
function or by giving stored bank blood. 
Potassium levels may become very high 
if blood is stored for a long time due to 
cellular release of ionized potassium. 
Hyponatremia may follow the rapid loss 
of salft if non-electrolyte replacement 
fluids are used primarily. The signs and 
symptoms in this condition are apathy, 
tachycardia, hypotension, weakness, and 
muscle cramps. 
H ypernatremia may exist prior to hydra-
tion due to hemoconcentration. This is 
generally changed into a mild hypona-
tremia with hydration. 
ROUTE OF REPLACEMENT FLUIDS 
In severe dehydration, with or without 
accompanying acidosis, intravenous re-
placement therapy is imperative. Oral 
feedings may be continued, but care 
should be exercised to avoid water 
intoxication. 
Interstitial therapy is contra-indicated 
since the sluggish circulation of the infant 
will not absorb the fluid readily. Further-
more, if non-electrolyte solutions are given 
interstitially they will further deplete the 
blood electrolytes by osmosis. 
TREATMENI' 
A. Treatment of Dehydration 
and Acidosis 
There are two stages: 
(1) establishment of normal blood 
volume and renal function 
(2) electrolyte replacement and 
correction of acidosis 
Stage I 
Ringer-lactate solution is ideally suited 
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to accomplish this stage. This solution 
provides water to increase the blood vol-
ume, electrolytes for deficit repair, and 
lactate which spares protein and prevents 
further ketosis. 
Approximately 10 c.c. of Ringer-lactate 
per pound body weight may be given at 
a rapid rate. 
Contra-indicated fluids are: 
(1) Whole blood-may cause heart 
failure because of addition of a concen-
trated solution to an already concentrated 
fluid. 
(2) Non-electric solutions - decrease 
blood electrolyte levels with hydration. 
Stage II 
On entering this stage a complete 
assessment of the blood should be done. 
Before instituting treatment with alkalis 
adequate renal function should be estab-
lished. 
Various rules are used for determining 
the amount of 1/6 Molar sodium lactate 
to use such as: 
(1) (60 - C02 C.P.) x 0.8 x lb wt 
= c.c. needed. 
2 
(2) 4.2 c.c. 1/6 molar lactate per kilo-
gram of body weight to raise the 
C02 content per Milliequivalent 
per litre. 
The acidosis should be corrected to 
about 18 mEq. and only in increments of 
10 mEq. at a time. Following this ther-
apy any existing electrolyte deficit may 
be corrected by giving additional Ringer-
lactate, whole blood, or specific oral re-
placement. Fresh whole blood has the ad-
vantage of replacing electrolytes, correct-
ing any existing anemia, and providing 
proteins. 
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Total fluids for the first 24 hours 
should be in the range of 75-100 c.c. per 
pound body weight. This total may be 
reached by giving 5% glucose in distilled 
water in addition to the previous fluids. 
After the first 24 hours 40-50 c.c. of 
fluid per lb. body weight should be 
given as : 
(1) Ringer-lactate - 10 c.c. per lb. 
body wt. per 24 hrs. 
(2) 5% glucose in D/W - 30-40 c.c. 
per lb. body wt. per 24 hrs. 
(3) whole blood and oral feedings-
subtract amount given from 5% 
glucose in D/W. 
B. Medication and o,.aJ Feeding 
(1) Medication - Appropriate medica-
CLINICAL NEUROLOGY 
F. A. Davis Co., Philadelphia. 
This third edition of the author's text 
contains revised information on several 
topics. Poliomyelitis, aneurysm, menin-
gitis, neurosyphilis, epilepsy and encepha-
litis are but a few of the topics which 
have been rewritten and brought up to 
date. 
Dr. Alper presents concise, detailed in-
formation in a manner which is dear and 
readily assimilated. The initial three chap-
ters of the book deal with the examina-
tion of the central nervous system, the 
interpretation signs and symptoms and 
the diagnosis of the nervous system dis-
ease. A host of topics are discussed in 
subsequent chapters. These topics in-
clude headache, vertigo, coma and pain; 
neuritis and neuralgia; diseases of the 
82 
tion should be given to combat the 
causative factor. 
(2) Oral Feeding-Oral feedings may 
be discontinued during the first 
12-48 hours, but continued lack of 
of oral feeding will result in star-
vation of the infant. 
If oral feedings are given at the 
onset it is wise to start each with 
small quantities of Ringer-lactate 
or glucose water solutions, increas-
ing the feedings as the diarrhea 
improves. 
Finally, the child may be started 
on protein milk (3 ounces per lb. 
body wt.) and the intravenous 
discontinued. 
meninges; vascular diseases of the brain; 
cranial trauma; tumours; abscesses of the 
brain; extrapyramidal disease; multiple 
sclerosis; intoxication and injuries by 
physical agents; vegetative nervous sys-
tem and endocrine disorders; nuclear 
amyotrophies and myopathies; degenera-
tive diseases; congenital and development 
disorders ; diseases of the skulf and 
vertebrae. 
The various diseases are discussed un-
der the headings of etiology, symptoms, 
diagnosis and treatment. The written 
script is illustrated with photographs of 
lesions and clinical cases, numerous dia-
grams and tables of differential diag-
nosis which contribute much to the text. 
This is an excellent book which should 
be of interest to students and practitioners 
alike. 
-David Lawson, '57 
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Boeck's Sarcoid 
Stanley Iwan. '55 
Boeck's Sarcoid is first introduced to the student of clinical medicine in the 
differential diagnosis of respiratory, neurological or other clinical disease entities. 
The discussion terminates here, however, and nothing further is mentioned about 
this dise.ase because it appears far down on the list of differe.ntial diagnoses, and 
until recently has been considered a rare clinical entity. 
To discuss fully the subject of Sarcoidosis is beyond the scope of this paper, 
as· new concepts about the etiology, diagnosis and treatment of the disease are 
now rapidly being published. An attempt will be made, however, to outline some 
of the main features of the disease and to present a review of some of the more 
recent literature. 
Historically, the first case was reported by Jonothan Hutchinson in 1875. 
In 1889 Besnier described a case in which the patient had violaceous swellings 
on the nose, ears and areas about the interphalan~eal joints. He termed this con-
dition "Lupus pernio". About the same time Boeck described a case of gener-
alized lymphadenopathy and he titled the disease "Multiple Benign Sarcoid of 
the Skin", presumably because the histology resembled that of sarcoma. 
In 1914 Schaumann first described the disease as a distinct clinical entity 
and linked the previous descriptions of Boeck and Besnier together as a specific 
disease. In 1920 Jungling emphasized the typical bone lesions and feeling that 
they were tuberculous in nature, caiJed the disease "Osteitis Tuberculosa Multi-
plex Cystia". Prior to this, in 1909, Heerfordt described the syndrome of uveo-
parotid fever and it was not until twenty-five years later that Bruins Slot in 
Scandinavia, Poutrier in France, and Longscope and Pierson in the United States 
recognized and proved this to be a unique manifestation of Sarcoidosis. The 
disease is now variably titled, the two most common names used being Boeck's 
Sarcoid and Sarcoidosis. 
DEFINITION 
The definition of Sarcoidosis as set 
forth in the Conference on Sarcoid by the 
U.S. National Research Council in 1949 
serves to illustrate how little is actually 
known about the condition. By defini-
tion, Sarcoidosis is a disease of unknowu 
etiology. Pathologically it is characterized 
by the presence in any organ or tissue of 
epithelioid cell tubercles with inconspic-
uous or no necrosis and by the frequent 
presence of refractile or apparently cal-
cified bodies in the giant cells of the 
tubercles. The characteristic lesion may 
be replaced by fibrosis, hyalinization or 
both. Clinically, the lesions may be wide-
ly disseminated. The tissues most fre-
quently involved are lymph nodes, lungs, 
skin, eyes and bones particularly of the 
extremities. The clinical course usually is 
chronic with minimal or no constitutional 
symptoms. However, there may be acute 
phases characterized by a general reaction 
with malaise and fever or there may be 
signs and symptoms referable to the tis-
sues and organs involved. The intra-
cutaneous tuberculin test is frequently 
negative; the plasma globulins are often 
increased. The outcome may be clinical 
recovery with radiographic evidence of 
residue or impairment of function of 
organs involved, or a continued chronic 
course of the disease. 
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INCIDENCE 
General-Hodgson and Woolner of the 
Mayo Clinic feel sarcoidosis is probably 
far more common than is generally sus-
pected. Schonholzer, in 1947, reported 
the incidence of sarcoidosis in the Swiss 
Army as being 13 per 100,000, while in 
the same year Ross-Smith reported the in-
cidence in Oxfordshire as being 0.66 per 
100,000 population. Michael, Cole et al 
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in a survey of the U.S. Army reported 
the incidence of sarcoidosis as being 0.88 
per 100,000 in white soldiers and 17.81 
per 100,000 in Negro soldiers. 
Age-Sarcoidosis occurs predominantly 
in the 20-40 year age group but can occur 
at any age. The youngest case reported 
was in a four month old child, while sev-
eral other cases in children under 15 
years of age have been reported. The dis-
ease has been found in people over 70 
years of age. 
Race-In the American series, some au-
thors report as high as 86% of cases 
occurring in the Negro. Conversely, 
Scandinavian authors report a predomi-
nantly white involvement. Hence all 
races may be affected, with a higher in-
cidence in the Negro. 
Geography-Sarcoidosis is world-wide in 
distribution and all strata of society are 
affected, although the lower income 
groups predominate. In a World War II 
Survey, Cone noted that a heavy concen-
tration of his 350 cases was in the south-
eastern portion of the country and were 
mostly rural. Other authors have also 
noted a preponderance of cases coming 
from rural districts. 
ETIOLOGY 
Although there are cases where more 
than one member of a family has had 
sarcoidosis there is no indication of a 
familial or inherited tendency towards the 
disease. Similarly there is little to sug-
gest a link with occupation. Proof of the 
statement that the true etiology of sarcoid 
is unknown is reflected by the large num-
ber of etiological concepts put forth, each 
of which has its own group of propon-
ents. The following concepts are dis-
cussed briefly and their popularity com-
mented upon. 
Bacterial Theories 
Brucellosis- The Brucella organism was 
once implicated as a cause, but the 
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Brucellergen test is negative in sarcoid-
osis. Michelson, after a careful study of 
eight classical cases of sarcoidosis stated 
that there was no connection with 
Brucella. 
Treponema Pallidum - The absence of 
postive serologic reactions and the fail-
ure to elicit a history of contact are 
strong arguments against this theory. Fur-
ther contra evidence exists in the differ-
ence in histological appearance of the two 
granulomata as well as the absence of 
Treponemes in the sarcoid lesions. 
Mycobacterium Leprae--Sarcoid patients 
have been tested for the lepromin re-
action but only slight or infrequent re-
actions have occurred and there is no in-
dication that sarcoidosis is an atypical 
tuberculoid leprosy. Some authors sug-
gest it may be a pleomorphic form be-
tween tuberculosis and leprosy, but this 
is doubtful because of the geographic dis-
tribution, incidence and the lack of in-
trinsic organisms in sarcoidosis. 
Mycobacterium Tuberculosis-For years 
arguments have raged between the sup-
porters of an anergic tuberculous reaction 
and the faction claiming that tuberculosis 
was in no way associated with the cause 
of sarcoidosis. The following points have 
been brought out and discussed: 
Histologic Appearance-Caseation is ab-
sent or extremely rare in sarcoidosis, 
while it is quite common in tuberculosis. 
Fibrinoid degeneration occurs more com-
monly in sarcoidosis than in tuberculosis. 
The sarcoid giant cell differs slightly 
from the tuberculous type. On silver stain-
ing a fine reticulum is present in sar-
coidosis, but this also occurs in non-
caseating tuberculosis. No definite proof 
of the cause of sarcoidosis can be deter-
mined by histological appearance how-
ever, since syphilis, leprosy, typhoid, bru-
cella, tularemia and other granulomatous 
diseases give a very similar picture. 
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Presence or Absence of Mycobacterium 
Tubermlosis- Tbe tubercle bacillus is ab-
sent in the authentic cases of sarcoidosis. 
If it is present, it is there as a secondary 
invader or a dubious diagnosis of sar-
coidosis has been made. Kyrle states that 
the foreign body type response seen in 
sarcoidosis and that seen in response to 
the disintegration products of tubercle 
bacilli are the same and he postulates that 
organisms are present in the early lesion 
and then disappear. However, the corre-
lation between finding tubercle bacilli and 
sarcoidosis together is that of random 
chance, or no greater than that of find-
ing the co-existence of tuberculosis and 
Hodgkins Disease. 
Results of Tuberculin Skin Test-In sar-
coidosis, the intracutaneous test is usually 
negative even when a dose of 1 mgm. of 
old tuberculin has been used. 76.4% of 
the general population and 80-85% of 
special population groups, i.e. doctors, 
nurses, etc., react to the tuberculin test 
while only 5-35 % of sarcoids show a 
positive tuberculin reaction. This latter 
figure varies with the individual series. 
The lack of response is attributed to 
anergy and is rarely reversed if the sar-
coid patient is vaccinated with B.C.G. 
A ssociati011 of Tuberculosis and Sarcoid-
Sarcoidosis terminates in tuberculosis in 
10-25 % of cases only, suggesting that the 
tubercle bac;illus when found is a second-
ary invader in a previous disease process. 
Serological Studies-By using the highly 
sensitive complement fixation test, it was 
shown that only 27 % of sarcoid patients 
had tuberculous antibodies while 62% of 
tuberculous patients had these same anti-
bodies. 
Age-The incidence of tuberculosis in-
creases with age as is demonstrated by 
skin testing, case histories and X-ray sur-
veys. Sarcoidosis, however, is most promi-
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nent in the 20-40 year age group with 
only rare cases being reported in the ex-
tremes of life when tuberculosis is quite 
common. 
Organs Involved-The organs involved 
in the two diseases are much the same 
in some instanc;es, e.g. lungs, spleen, liver, 
lymph nodes and bone marrow. Sar-
coidosis has, however, a much higher in-
cidence of uveal, parotid and myocardial 
involvement. Rich has pointed out that 
sarcoid can pepper the lungs and not in-
volve the spleen and liver, a condition 
never seen in tuberculosis. 
By using eighteen mycobacterial tuber-
culins and one control preparation in 
seven sarcoids and five healthy controls, 
it was noted by Brooke and Day that 
there was no significant difference in the 
response of the two groups. Hence this 
was considered evidence against tubercu-
lous causation. 
The tuberculous theory of causation 
has been argued for many years with no 
significant advance being made by either 
side. Many authors, including Longcope, 
now feel that new fields must be explored 
before the cause of sarcoidosis will be 
found. 
Parasitic and Protozoal Theories 
Leishmaniasis - This condition gives a 
similar histological appearance to sar-
coidosis and also a hyperproteinemia, but 
the geographic distribution and lack of 
proof of the presence of intracellular or-
ganisms rule against it. 
Helminths-In 1952 Jaques described a 
case in which larvae of Strongyloides 
stercoralis were found in the patient's 
peroneal tissues. On histological exami-
nation he showed a Schaumann body ·be-
ing formed from this larva and it is well 
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known that Schaumann bodies do occur 
in sarcoid giant cells. Jaques found three 
other cases in which Nematodes were im-
plicated and he feels more conclusive 
proof could be obtained if stool exami-
nations for parasitic ova and larvae were 
carried out on sarcoid patients. He also 
feels that the geographic distribution, the 
epidemiology, the racial predilection, the 
organs involved and the results of labora-
tory studies show a good correlation be-
tween sarcoidosis and Nematode in-
festations. 
It bas also been shown experimentally 
in guinea pigs that the histological re-
sponse to various antigenic principles of 
Nematodes is granulomatous and that no 
close association with the larva itself is 
necessary to produce the granuloma. 
Fungi 
Many Scandinavian authors stressed the 
relationship between sarcoidosis and strep-
tothrix, especially in regard to tonsillar 
lesions. Streptothrix is so common a 
contaminant that it is unlikely that it 
plays any part in causing sarcoidosis. 
Longcope and Pierson failed to grow 
fungi from sarcoid lesions on Sabouraud's 
medium. Agglutination by several fungal 
sera and complement fixation were ab-
sent in seven cases of sarcoidosis reported 
by Harrell. 
Virus 
In 1932 Kissmeyer prepared an anti-
gen from a cutaneous lesion of sarcoidosis 
which led to a specific skin reaction. The 
mode of preparation suggested the pres-
ence of a virus. 
Kveim's antigenic test solution was pre-
pared in a similar manner and the re-
sponse to it was interpreted as a specific 
allergic reaction to a specific virus. Nu-
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merous other authors have made viral 
type suspensions and used them t o get a 
similar positive skin reaction. However, 
the Frei test was negative in sarcoid pa-
tients and this was felt to cast some doubt 
on viral etiology. 
Beryllium 
Higgins tn 1947 described 3~ cases 
of pulmonary sarcoidosis, 30 of whom 
worked in one plant. All but two of the 
3~ were engaged in the manufacture of 
fluorescent lamps. Other writers have 
also suggested the close association of 
chronic beryllium granulomatosis and sar-
coidosis but the evidence so far accumu-
lated is inconclusive. 
Foreign Bodies 
Revfem, using polarized light, examined 
1000 cases of sarcoidosis. A few speci-
mens contained refractile material (in one 
case calcareous spar) which Revfem felt 
might be responsible for a limited num-
ber of cases of sarcoidosis 
Calcareous spar is found in the soil 
of Cambrosilurian regions and sarcoidosis 
is more prevalent in rural areas, espe-
cially among farmers and gardeners. An 
air borne dust (a few microns in size) 
could enter the blood stream and lym-
phatics to produce a generalized disease. 
The material might be removed, dissolved 
or converted into amorphous, non-injuri-
ous compounds. 
Neoplasm 
In this etiological concept, sarcoidosis 
is compared to the lymphomata and 
Hodgkin's Disease. In 19~0 Gherardi pre-
sented a case of common hepatic duct 
carcinoma in which examination of a 
regional node revealed confluent granu-
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lomata of sarcoidosis. No other granu-
lomata were found at autopsy, and it was 
felt this was a local rather than a gen-
eralized form of the disease. 
Many similar cases have been presented 
in the literature, with the difference be-
ing that the primary tumor was in breast, 
lung, thyroid and many other organs. 
PATHOLOGY 
Sarcoidosis is a generalized systemic 
condition capable of involving every 
organ in the body. The disease is char-
acterized by round circumscribed masses 
resembling miliary tubercles composed of 
focal areas of large mononuclear cells of 
epithelioid structure, and occasional mul-
tinucleated giant cells. The epithelioid 
cells often give the impression of being 
larger and having more nuclei which are 
often distributed evenly through the cell 
rather than having a peripheral or polar 
arrangement as is the picture in tubercu-
lous epithelioid cells. Neutrophilic leuko-
cytes and caseous necrosis are usually ab-
sent. Reticulin fibres are demonstrable in-
tact throughout the nodule, in contrast to 
the breakdown and disappearance of these 
fibres in caseous tuberculous lesions. 
A few lymphocytes may be present in 
and around the focal lesion, but usually 
are less numerous than in tuberculous 
lesions. The focal lesions of sarcoid tend 
to be sharply circumscribed and are sep-
arated from the surrounding tissues which 
appear normal and show no evidence of 
inflammatory reaction. On silver stain-
ing, however, a delicate reticulum be-
tween granulomata is revealed. 
Various types of inclusions have been 
found in the giant cells. These include 
"spiculated bodies" or "asteroid bodies". 
The asteroid body is chemically stable but 
is not pathognomonic of sarcoid lesions 
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since it is found in giant cells of other 
granulomatous lesions. 
Another inclusion commonly found is 
the Schaumann Body which is variable in 
size. It is a round or oval, non-crystal-
line, laminated, doubly refractile body 
with a two-layered membrane. This body 
may frequently fill a giant cell or burst 
out and lie in the intracellular spaces. It 
is not acid-fast. This body is also non-
specific since it can occur in leprosy, 
tuberculosis and lupus erythematosus. 
Jaques, however, relies heavily on the 
Schaumann body to substantiate the Ne-
matode theory of causation. 
Other inclusion bodies found in the 
giant cells are spindle-haped, radial or 
irregular and may give staining reactions 
characteristic of elastic tissue, calcium or 
iron. 
Hannesson described an early "presar-
coid" lesion of lymph nodes consisting of 
a non-specific proliferation of the littoral 
sinusoidal reticulo - endothelium which 
choked the lymphatic sinusoids. An early 
granuloma occurs in juxtaposition to such 
a sinusoid. 
The granulomas all appear at the same 
stage of development but heal in various 
fashions and rates. For rigid diagnosis, 
no caseation should be present, but Hodg-
son and W oolner feel that small foci of 
caseous necrosis with the absence of 
Tubercle Bacilli are compatible with the 
diagnosis of sarcoid. Fibrinoid necrosis 
can occur in any of these granulomata. 
Healing in sarcoidosis occurs by pro-
gressive fibrosis and hyalinization with-
out calcification. The lesions are replaced 
with a cellular whorled collagen and may 
give an amyloid staining reaction (paramy-
loidosis) with eventual conversion into 
small sclerotic nodules. 
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To facilitate an appreciation of the pre-
senting clinical symptoms, a discussion of 
the organs involved and the incidence of 
this type of presentation will be men-
tioned. A description of some of the 
more salient clinical pathological features 
is also included. 
Lymphatic Involvement 
Superficial and deep nodes are involved 
in 87% of cases of sarcoidosis, while 
Boyd claims that the deep nodes alone 
are affected in 75% of cases. Lympha-
denopathy, either generalized or local-
ized, is the most frequent presenting sign. 
Pulmonary Involvement 
The lungs are involved in 76-90% of 
cases and a variety of lesions appear on 
radiological and postmortem examination. 
The lesions occur predominantly in the 
glands draining the lungs and/or in the 
lymphatic channels and interstitial tis-
sues of the lung parenchyma. The pul-
monary lesions are of the following types: 
1. Bilateral, symmetrical involvement of 
the hilar and bronchial nodes without 
evidence of parenchymal infiltration. 
2. Mediastinal node involvement with 
varying degrees of parenchymal in-
filtration . 
3. Parenchymal lesions resembling mil-
iary T.B. 
4. Discrete nodular infiltration of the 
parenchyma with or without hilar node 
involvement. 
5. A diffuse or confluent parenchymal 
infiltration. 
6. Parenchymal involvement, with pleural 
involvement is very rare. 
Skin Involvement 
Skin involvement occurs in 27-30% of 
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cases and is more commonly seen in the 
Negro. The skin lesions are of three 
types: 
1. Small, discrete, elevated nodules which 
appear on the face about the eyelids, 
nares and ears. These lesions are 
small, elevated, pitted or umbilicated 
and may be yellow or purple in colour. 
2. Large nodules or masses which in-
volve the subcutaneous tissues and are 
smooth and purple, occurring about 
the nose and joints. These are the 
lesions named "Lupus Pernio" by 
Besnier in 1889. 
3. Large flat plaques, finely granular or 
scaly which cover large patches of the 
skin. 
The skin lesions cause varying degrees 
of tissue distortion. In no case reported 
was the skin involvement present with-
out evidence of other organs being in-
volved by the sarcoid lesions. 
Cardiac Involvement 
Sarcoidosis can involve all three lay-
ers of the heart, and cardiac involvement 
is present in up to 20% of diagnosed 
cases. Galveson was the first to note ab-
normal ECG changes which included 
heart block and cardiac arrhythmias all 
of which were refractive to the usual 
methods of therapy. Boyd has seen two 
cases of severe cardiac involvement which 
caused the patients' death. Several other 
similar cases are reported in the literature. 
The Spleen 
The spleen on pathological examina-
tion is the second most frequently involved 
organ, but clinically splenomegaly is very 
rare. One case of a ruptured spleen in-
volved by sarcoidosis has been reported. 
The C.N.S. 
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Colover, in a series of 115 cases, noted 
that the facial nerve was involved in 50% 
of cases. The optic, auditory and glosso-
pharyngeal nerves are also involved, but 
far less frequently. Sarcoidosis may in-
volve the brain itself as well as the men-
inges and thus be a direct cause of death. 
The patient will present to the neurologist 
signs and symptoms relative to the area 
of the brain involved. 
Eyes a11d Uveoparotid Fever 
Longcope states that 22% of his series 
of 607 cases had ocular involvement of 
some type or other. The Negro is more 
frequently affected and the lesions may 
be a granular uveitis which is most com-
mon, but iritis also does occur. Any part 
of the eye may be affected, and nodules 
on the eyelids are considered diagnostic 
of sarcoidosis by Harrell and Friedman. 
The lesions usually regress and heal, leav-
ing partially impaired vision, but may 
progress to glaucoma and cataracts in the 
end stages. 
Uveoparotid fever is seen usually in the 
second and third decades. Paresis of the 
facial nerve follows the prodromal symp-
toms of lassitude, general malaise and 
fever, etc., and soon the parotid swells. 
Uveitis always occurs, and other ocular 
lesions may be present. The facial nerve 
paresis clears rapidly; the fever lasts weeks 
or months; the parotid swelling may last 
even longer. The ocular lesions regress 
slowly with considerable scarring and im-
pairment of vision. 
Digestive System 
The liver is predominantly and most 
frequently involved, but only rare cases 
of liver dysfunction have been reported. 
The portal areas are commonly involved. 
The occasional American centre advocates 
the use of liver biopsy in diagnosis. 
Rare stomach involvement may simu-
late a gastric ulcer, but diagnosis can only 
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be made by examination of the tissue. 
Wilson et al felt sarcoidosis was the cause 
of regional ileitis, but Snapper and Pim-
pen feel strongly that there is no relation-
ship between the two diseases. 
Bone Marrow 
Katz and others feel that 10-20% of 
sarcoidosis involves the phalanges, meta-
carpals and metartarsals. The bone lesions 
are solid and start in the same marrow. 
Histologic proof of the nature of the 
osseous lesions is less common than the 
literature leads one to believe because bone 
marrow biopsies are infrequently done. 
Despite the invasion of bone marrow, 
anemia is a very rare complication of 
sarcoidosis. 
Miscellaneo11s 
Other organs rarely involved include 
the kidney, bladder, pituitary and thyroid. 
Boyd reports two cases of diabetes in-
sipidus because of pituitary involvement. 
Kidney involvement may precipitate mild 
kidney failure, and in one case hypercal-
cemia due to sarcoidosis was discovered 
when repeated rapidly forming kidney 
stones were noted. 
DIAGNOSIS 
Because of its lack of specificity and 
its protean manifestations, a diagnosis of 
sarcoidosis is difficult, and is infrequent-
ly made. Many cases are picked up by 
chance examination, and on thorough 
questioning of the patient no history or 
complaints of any nature can be elicited. 
Many cases may present with very vague 
and minor symptoms and then dear spon-
taneously with time, with no therapy and 
no adequate diagnosis having been made. 
Sarcoidosis per se infrequently causes 
death. Death results usually from com-
plications of the original disease process. 
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Because of the multiplicity of organ in-
volvement the sarcoid patient may pre-
sent himself at the office of an ophthal-
mologist neurologist, interrist or derma-
tologist, each of whom can make the 
diagnosis on the presenting symptoms. 
(The presenting symptoms are primarily 
those of the organ system most seriously 
involved.) The general clinical manifes-
tations of the disease in order of their 
decreasing frequency are: 
1. lymphadenopathy 
2. dyspnea 
3. skin eruptions (lupus pernio) 
4. weight loss 
5. expectoration 
6. fatigue and malaise 
7. fever 
8. anorexia 
9. chest pain 
Other associated presenting symptoms 
may include parotid swelling, joint pains, 
swelling of the hands and feet, abdominal 
pains or masses, hoarseness, nausea and 
vomiting and various neurological mani-
festations. 
The symptoms noted above and their 
relative frequency of occurrence were 
classified by Longcope in a series of 494 
cases. In this same series 13.5% of pa-
tients were completely asymptomatic. 
The syndrome of uveitis, parotitis and 
facial nerve palsy first described by Heer-
fordt in 1909, has allowed the astute 
clinician to diagnose sarcoidosis on a 
number of occasions on clinical grounds 
alone. 
Laboratory Findings 
Urine-Urinalysis is usually normal, but 
occasionally Bence-Jones proteinuria has 
been observed. even in the absence of bone 
lesions. 
Blood-Sarcoidosis is rarely accompanied 
by a slight microcytic anemia. The leuco-
cyte count is variable. If a leucopenia 
exists, then some authors feel that the 
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spleen is involved. The leucopenia is 
predominantly a neutropenia; but in most 
cases there is an accompanying peripheral 
eosinophilia which some authors use as 
an index of disease activity. This view 
is not universally supported . 
In nearly every series of cases, the 
E.S.R. was elevated, with values as high 
as 100 roms/ hr. being noted in a large 
proportion of cases. 
Serum Proteim-The serum proteins are 
nearly always elevated, with the total pro-
tein going as high as 9 gm/ 100 cc. This 
total is made up of a mild hypoalbumin-
emia and a fairly marked hyperglobulin-
emia with an accompanying reversal of 
the A./ G ratio. 
A. serum hypercalcemia with a normal 
or elevated serum phosphorus has been 
reported. In most of these cases, how-
ever, there was an associated elevation of 
the serum alkaline phosphatase. 
Miscellaneous findings consist of a nor-
mal or slightly depressed serum choles-
terol and occasionally impaired liver func-
tion tests and abnormal bilirubin excre-
tion. (These findings are more prone to 
occur if the liver involvement is very 
severe.) 
Because of the wide variation in symp-
toms and ordinary laboratory findings 
the slightest clinical suspicion of sarcoi-
dosis should be followed by other diag-
nostic aids, which include: 
1. Radiography 
2. ,Bronchoscopy 
3. Biopsy 
4. Bacteriological studies 
5. Kveim-Nickerson Skin test 
RAdiography--Otest radiography is ex-
tremely useful in picking up sarcoidosis 
in its early stages. The chance finding of 
chest involvement on routine chest X-ray 
leads to further examination of the pa-
tient" and thereby allows the clinician 
to discover the disease. Mclaughlin 
u.w.o. MBDJCAL }6UllNi\L 
gives a simplified description of the 
types of lung involvement seen in chest 
radiography: 
1. a diffuse, disseminated, nodular type 
of disease which is radiologically indis-
tinguishable from miliary tuberculosis. 
2. diffuse or localized changes of a 
linear or strand-like character, which ap-
parently follow the distribution of the 
bronchovascular ramifications and give 
prominent root trunks and peripheral 
markings. 
3. patchy, coalescent densities having 
the appearance of conglomerate fibrotic 
induration, usually diffuse and particu-
larly pronounced in the mid zone and 
basal portions. 
In association with the lung findings, 
the Mayo Clinic reports 15-20% of pa-
tients show radiographic bone involve-
ment. The lesions see.n are round, solid 
areas occurring primarily in the small 
bones of the hands and feet. Because of 
the small number of patients who have 
skeletal studies done, the percentage of 
bone involvement is a very controversial 
point. 
Bronchoscopy-Bronchoscopy is used to 
get a biopsy sample in cases where the 
lungs are primarily involved. Only rarely 
does tracheal or bronchial blockage occur 
with sarcoidosis, but one case has been 
reported in which the lesions were found 
involving the trachea itself and the 
resulting obstruction was removed by 
bronchoscopy. 
Biopsy-Biopsy is the one method of 
making a positive diagnosis. Any super-
ficial gland may be biopsied. If only 
intrathoracic glands are seen, a positive 
scalene node biopsy has been reported in 
many cases. Any tissue can be biopsied 
and some clinics advocate biopsy of any 
of the salivary glands, bone marrow or 
liver if lymphadenopathy is absent. Liver 
biopsy is positive in a high percentage 
of cases but many use the technique spar-
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ingly, because of its complications. Cases 
are reported where thoracotomy was per-
formed in order to make a diagnosis. 
Bacteriological Studies - Bacteriological 
studies are negative methods of diagnosis, 
since with the existing etiological con-
cepts, the presence of any bacteria negates 
a diagnosis of sarcoidosis, unless the bac-
teria are present as secondary invaders. 
The studies necessary are those routinely 
used to culture bacterial flora as well as 
specific methods to culture the tubercle 
bacillus and the various fungi. Once 
these methods show no growth, the diag-
nosis of sarcoidosis is plausible. 
Kveim-Nickerson Skin Test-The Kveim-
Nickerson test involves the intradermal 
injection of a heat-sterile suspension of 
human sarcoid tissue and the development 
of a skin reaction within a few weeks 
time around the point of injection. Using 
the presence of the skin reaction as well 
as a biop-sy and histological examination 
of the site of injection carried out 4-6 
weeks post injection, Siltzbach and Erlich 
found the following results in a series of 
192 patients: 
58 positive sarcoids--86% positive. 
80 sarcoid suspects--33 strong, 85% 
positive; 47 weak, 27% positive. 
54 with other diseases - 4% false 
positive. 
Using a control suspension of normal 
lymp node and splenic tissues, no re-
actions were noted. Since it shows a high 
degree of accuracy, this test is very use-
ful as a confirmatory diagnostic tool, 
especially if there is not tissue available 
for biopsy. The test is somewhat limited 
in its use because of the severity of the 
resulting skin reaction and the prolonged 
time (months to a year) that it takes for 
the reaction to disappear. 
In summary the main diagnostic cri-
teria are: 
1. Clinical and radiological evidence 
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2. Typical histological features shown 
in biopsy material 
3. Negative bacteriological studies or 
biopsy or necrosy material 
5. Laboratory evidence including the 
positive skin test 
TREATMENT 
A method of prophylaxis cannot be 
recommended until the etiology of the 
disease is known. Throughout the years, 
numerous methods of treatment have been 
tried for patients with sarcoidosis. Ultra 
violet light, X-rays and radium have been 
used extensively and although they may 
possibly benefit some superficial lesions, 
no satisfactory results are demonstrable in 
other tissues. Arsenic, tuberculin, calci-
ferol, various antibiotics, nitrogen mus-
tard and urethane have also been used. 
The occasional case has shown improve-
ment on these therapies, but none can be 
used with any degree of assurance of ob-
taining cure beyond that of random 
chance. 
The antituberculous drugs streptomycin, 
dihydrostreptomycin and isoniazid have 
been given thorough trials, but with little 
success. The literature now being pub-
lished stresses only the ineffectiveness of 
these drugs in sarcoidosis. This seems to 
be further proof that tuberculosis and 
sarcoidosis are different diseases. 
The only encouraging reports of suc-
cessful treatment are those following the 
use of dihydrotachysterol, ACTH and 
Cortisone. Although effective on numer-
ous occasions, the use of dihydrotachys-
terol is limited by the drug's toxic effects. 
Many glowing reports appear about 
the marked clinical and radiological im-
provement obtained from ACTH and 
Cortisone therapy, but Woolner and 
Hodgson at the Mayo Clinic feel that 
these are the exceptional rather than the 
common findings. Mostly the improve-
ment is limited to the clinical response, 
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with no appreciable radiological change. 
In ACTH and Cortisone therapy, one 
must always be aware of the dangers asso-
ciated with their use in the presence of 
tuberculosis. The regime used by these 
men at the Mayo Clinic consists of 100 
mgm of Cortisone daily until a remis-
sion occurs or until one to two weeks of 
treatment have elapsed. The dosage is 
then slowly diminished to a maintenance 
level of 50 mgm per day. 
If ACTH is used, the initial dose should 
be 60-100 mgm per day with a gradual 
reduction after 1-2 weeks of therapy to 
a maintenance level of 10 to 25 mgm 
per day. Therapy may have to be main-
tained for weeks or months if progressive 
clinical improvement is noted. 
Ocular lesions regress well with ACTH, 
and lung lesions respond to either ACTH 
or Cortisone. However, Siltzbach noted 
a relapse rate of 70% once therapy was 
stopped, and he felt these drugs had little 
effect on the natural course of the disease. 
Many patients with lung involvement 
seem to have worse pulmonary function 
following therapy. Stone et al suggest 
these people were in the granulomatous 
stage of the disease and that the lesions 
healed rapidly with marked hyalinization 
and resulting severe pulmonary fibrosis. 
Surgery is used most infrequently in 
sarcoidosis, with its main contributions 
being in the field of biopsy to get tissue 
for diagnosis and very rare splenectomy 
when splenic symptoms are severe. 
In evaluating the success of any ther-
apy one must be cognizant of the natural 
course of the disease and realize that most 
patients tend to improve without therapy. 
Hence the aim of the therapist in using 
ACTH, Cortisone or any drug should be 
to carry the patient temporarily until 
spontaneous remission occurs or is in-
duced by the therapy as happens in a 
small percentage of cases. 
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PROGNOSIS 
The prognosis of sarcoidosis is ex-
tremely variable, since the disease onset 
is very insidious and the disease itself 
may remain completely asymptomatic. 
Once diagnosed and treated it may remain 
latent for years and then suddenly flare 
up and proceed to fatal termination. 
In Leitner's 1949 series death resulted 
primarily from secondary complications. 
The causes of death were classified as 
follows: 
46% from cardiac failure 
20% from superimposed tuberculosis 
16% from CNS sarcoidosis 
18% from secondary bacterial infec-
tions and miscellaneous causes. 
Several cases of heart failure· due to 
myocardial sarcoidosis have been reported, 
but usually failure occurs secondary to a 
cor pulmonale resulting from a severe lung 
fibrosis. 
King and Reisner, in a series of 64 
cases, showed that at the end of 3 years: 
36 cases or 56.2% had cleared totally 
or partially; 
16 cases or 25 % remained static; 
12 cases or 18.8 % had progressed. 
CLINICAL CHEMISTRY 
IN PRACTICAL MEDICINE 
C. P. Stewart, Reder in Classical Chemis-
try; D. M. Dunlop Christison, Professor 
of Therapeutics and Clinical Medicine, 
University of Edinburgh. 320 pages, 
illustrated. E. and S. Livingstone LJd., 
Edinbttrgh and London, 1954. 
This book is a refreshing, clear, con-
cise and comprehensive review of the field 
of practical clinical chemistry. One is 
impressed with the clarity of expression 
ana the ease with which the authors pre-
sent their material. 
The book contains the following topics: 
the collection and preservation of sam-
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On an overall study, Carr and Gage at 
the Mayo Clinic give a 5 year survival 
rate of 92.9% and a 10 year survival of 
80% . Cowdell in England gives a rate 
only 2-5 % below that quoted above. Thus 
we see that the prognosis for life is good, 
but that the prognosis for the healing of 
the lesion and disappearance of symp-
toms is only fair. 
In conclusion, little has been done to 
advance our knowledge of sarcoidosis un-
til recently. However, with the develop-
ment of better diagnostic methods, the 
incidence of the disease is greater than 
previously was suspected. Many etio-
logical theories have been advanced and 
remain as theories, with little or nothing 
positive being known of the actual cause. 
This hck of knowledge limits the thera-
peutics applicable to the treatment of the 
disease to non-specific and empirical en-
tities. It is to be hoped, therefore, that in 
the near future, the etiology of the dis-
ease will be more clearly defined and spe-
cific therapies found. Until then, one can 
only endeavour to make the clinician more 
aware of the existence of the condition 
so that it may be diagnosed and treated 
with the drugs now showing the most 
success. 
ples; water and electrolyte metabolism; 
neutrality regulation ; carbohydrate met-
abolism; tests of renal function; the pro-
teins of blood plasma; tests of gastric, 
pancreatic and hepatic function ; the cere-
bro-spinal fluid ; assessment of thyroid 
function; calcium and phosphorus; hor-
mone abnormalities; nutritional defici-
ences. The theory behind the clinical 
chemical tests is presented in a simple 
but didactic manner. Included are a num-
ber of excellent graphs and tables which 
summarize the written portion of the text 
as well as presenting other useful data. 
Various tests and their limitations are in-
cluded in an appendix, making them 
available for quick reference. 
-Victor Priebe, '57 
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PEARCE GOULD'S ELEMENfS 
OF SURGICAL DIAGNOSIS 
10th Edit. Sir Cecil Wakely, P4111 B. Hoeber 
Inc., The Ryerson Preu. 
This text is one which should prove to 
be of great value to the student who is 
commencing the study of clinical medi-
cine and surgery. The book has been 
written primarily for this purpose. In gen-
eral it is intended for reference work, but 
also contains excellent material for re-
viewing purposes. 
The author presents and discusses sur-
gery from the viewpoint of clinical symp-
tomatology. This type of organization is 
excellent for the student who has to re-
view a great deal of material in a limited 
time. The text contains seventy-nine 
plates, 556 pages and an excellent index. 
Gould's Elements of Surgical Diagnosis 
should prove to be a popular book. 
-Marvin L. Kwitko, '56 
THE FOUNDATIONS 
OF SURGERY 
George Perkins, F.R.C.S. E. and S. Lifling-
stone, Edinburgh and London; The Mac-
millan Co. of Canada, Lid. 
This simple surgical text is exactly what 
the author states - elementary, basic, 
pocket-sized and concise. Each topic is 
arranged under the headings of symp-
toms, treatment and rehabilitation. Topics 
included in the book are: healing of 
wounds; burns; infection; examination of 
body parts; coma and collapse; disc 
surgery. 
This is a small text which will help 
prepare the neophyte for the more for-
midable text-books of surgery. 
-Travis Kaylor, '57 
GLANDULAR PHYSIOLOGY 
AND THERAPY 
Multiple t~~~thors. J. B. Lippincott Company, 
Montreal. (Prepared under the t~~~spices 
of the Council on Pharmacy and Cbem-
istry of the American Medical Associa-
tiotl), Ed. 5, 1954. 
This work leaves one with the im-
pression that nothing has been omitted 
except that experimental detail which is 
often superfluous to the average reader 
and which, in fact, mars some of our 
otherwise excellent reference text-books 
on physiology. This text, on the other 
hand, includes sufficient experimental 
data to make the book both tnteresting 
and authentic. 
The emphasis in each chapter has been 
placed upon treatment, but the tradi-
tional approach, with discussion of anato-
my, physiology and abnormalities of 
function , has been followed in order to 
give a better understanding of the basic 
principles underlying treatment. 
Twenty to thirty years ago the physi-
ology of the endocrine glands was fairly 
well understood. However, the clinician 
was still besieged by an infinite number 
and variety of hormones, pseudohormones, 
and general hormonal elixirs of life and 
fountains of youth which were claimed 
to cure everything from athlete's foot to 
dandruff. In other words, what to do? 
Until the publication of this book, there 
were very few good references on actual 
application of the new substances which 
were gradually being isolated and puri-
fied for use. Hence, the original ed1tion 
of Glandular Physiology and Therapy was 
born in 1924. 
The value of this particular work on 
endocrinology is two-fold . Firstly, it is 
not a semi-rehashed version of an old 
textbook but is virtually a new work in 
each edition, since tbe material is gath-
ered from current journals (most of which 
are post-war). Secondly, each subject is 
dealt with by individual specialists in that 
particular field . Tbe whole work is scien-
tifically co-ordinated with an introdutory 
chapter by Hans Selye, Professor and 
Director of Experimental Medicine at the 
University of Montreal, and Paul Rosch, 
of Albany, New York; it is literarily co-
ordinated by the Committee on Publica-
tions, Council on Pharmacy and Chemis-
try of the A.M.A. 
The above-mentioned committee bas 
done an excellent job in editing a 
work which is easily read and under-
stood by tbe student, but which also 
provides the specialist with much con-
densed information. 
-Jay Webster, ''7 
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HENDERSON, Murray .... ...... .. ... .. ..... ....... ............................ .Victoria, London, Ont. 
HOBBS, Kenneth .... .. .. ..... ...... ............ .. ......................... ... ... .......... Civic, Ottawa, Ont. 
HUTSON, Richard ......... ..... .. ... ............. ... .... ............ .... ...... .......... . Civic, Ottawa, Ont. 
IRVINE, John ....... .... .... ....... ... ... .. .. ..... .................................... .Victoria, London, Ont. 
IW AN, Stanley ....................... .. ........ ... ... .. ... .......... .. .. ........... ... Western, Toronto, Ont. 
JACKSON, Harold ................. ..... ........... ..... ................. ......... General, Hamilton, Ont. 
JOHNSON, Harold ....... .......... .. ...... ..................................... General, Hamilton, Ont. 
JORY, Thomas ... ... ...... .. .. ..... ... .. ........... .. .......... ........... ..... ... ...... Victoria, Loncf.,..n, Ont. 
KINGSMILL, Sheila .. ........................ .. ................. .. ............... Victoria, London, Ont. 
KIRSH, Erving ................ ..... ... ......... .. .. .. ..................... .. ...... ... . General, Toronto, Ont. 
KNIGHT, Charles .... .... ... ....... .. .. ... ..... .... ... ........ ... ..... ... .. ...... .. .. Victoria, London, Ont. 
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NAME HOSPITAL 
MALONEY, Alan .......................... ................. ........ .. ...... . St. Michael's, Toronto, Ont. 
MATHIES, Helmut. .. .... .... ........ .... .. ......... .. ....... ... .... ... ...... .... ... Victoria, London, Oat. 
MORRISON, Joseph ..... .... .... ...... .......... . ...... .. ..... ... ..... . St. Joseph's, Hamilton, Ont. 
MOSSING, Shirley ........ .... ...... .... ....... ... .................. .... ....... .. ... General, Regina, Sask. 
MUNRO, Donald ..... .... .................. ....... ...... .......... ........ .. .. .... General, Hamilton, Ont. 
MacDONALD, Craig ..... ..... ..... ..... ........ .... ... .... .. ...... ................. Victoria, London, Oat. 
McKNIGHT, Kenneth ....... ........... .. .... .. ... ........... .......... ... .. .... .Victoria, London, Ont. 
McLEAN, William ....... ...... ... ... ........... ........ .... .. ........... ....... General, Hamilton, Ont. 
NATHAN, Max ........ ............ ....... .... ..... .. ... ... ... ......... .. ....... .... ... Victoria, London, Oat. 
PEARCE, George .. .... ....... ... .... .... ......... .......... ... ......... .. ........... General, Toronto, Ont. 
POLAK, Alexander .. .... .......... .. .. ..... ... .. .......... .. .............. .......... General, Toronto, Oat. 
PORTER, Robert. ............. .. .......... .......................... ..... ......... General, Hamilton, Ont. 
RHODES, John ... ...................... .................. .. ........ .. .. ...... ......... Victoria, London, Ont. 
ROBERTS, Richard ........ ... .... .. ......... .. .... .... .......... .. ..... ........... General, Montreal, P.Q. 
SALES, Jack ................. ..... ........ .... .. .. .. .. ... .. ............................. Victoria, London, Ont. 
SHAVER, Jack ......... .......... .. ... .. ....... ............. ... ................. .... .. General, Hamilton, Ont. 
STANTON, James .... .... ........................................................ St. Francis, Evanston, Ill. 
STRATFORD, Graham .. ...... .... .. ... ..... .. .. .................. . Royal Victoria, Montreal, P.Q. 
SWAN, Donald ................. ... ....... .............. ......... .. ......... ... ..... ....... Sinai, Detroit, Mich. 
THRENDYLE, Kenneth .. .................. ... ............................. ... Victoria, London, Ont. 
TURNBULL, Kenneth ...... ....... ... ..... .. .. .. ... .... .... .... .. .... ... .... .... ... General, Regina, Sask. 
TURNER, Robert. ............. ... .. ......... .... ........ ... .... ... .................................. London, Ont. 
UPMALIS, Henry ...... ...... ........ ........ ....... .. ...... .. ................ .. ..... Victoria, London, Ont. 
URSCHEL, John ...................... .... ........ .. .... University of Alberta, Edmonton, Alta. 
V ASARINSH, Pavils ...... .. .. ...................... .. .... ...... .. .... .... ...... General, Hamilton, Oat. 
WALLACE, John ...... .... ............. ........... ...... .. .. ........................ General, Calgary, Alta. 
WEBER, James .... .. .. ........ .......... .. ... .. ....... ..... ........... .... .. ..... ..... Western, Toronto, Ont. 
Y ANKOU, Cluis .... .... .................................. .. ................. East General, Toronto, Oat. 
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